<SEC-DOCUMENT>0001140361-23-022489.txt : 20230502
<SEC-HEADER>0001140361-23-022489.hdr.sgml : 20230502
<ACCEPTANCE-DATETIME>20230502163040
ACCESSION NUMBER:		0001140361-23-022489
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20230426
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230502
DATE AS OF CHANGE:		20230502

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Eterna Therapeutics Inc.
		CENTRAL INDEX KEY:			0000748592
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				311103425
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11460
		FILM NUMBER:		23879602

	BUSINESS ADDRESS:	
		STREET 1:		1035 CAMBRIDGE STREET
		STREET 2:		SUITE 18A
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02141
		BUSINESS PHONE:		(212) 582-1199

	MAIL ADDRESS:	
		STREET 1:		10531 4S COMMONS DRIVE
		STREET 2:		SUITE 166-550
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92127

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Brooklyn ImmunoTherapeutics, Inc.
		DATE OF NAME CHANGE:	20210325

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NTN BUZZTIME INC
		DATE OF NAME CHANGE:	20051230

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NTN COMMUNICATIONS INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>brhc20052311_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2022" xmlns:sic="http://xbrl.sec.gov/sic/2022" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:exch="http://xbrl.sec.gov/exch/2022" xmlns:cef="http://xbrl.sec.gov/cef/2022" xmlns:erna="http://eternatx.com/20230426" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 23.3.2.5148
         Copyright 1995 - 2023 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_21f381c9fb164dd18f6ce94bb19d81d1" contextRef="c20230426to20230426" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_70012f83b60c42189eb543ab4d706db1" contextRef="c20230426to20230426">0000748592</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="erna-20230426.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20230426to20230426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000748592</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-26</xbrli:startDate><xbrli:endDate>2023-04-26</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
    <div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES<br />
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_9f77ad0a939645e294dfb8a69d709812" contextRef="c20230426to20230426">8-K</ix:nonNumeric></div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_da84d6318532426ca195e2c080847c19" contextRef="c20230426to20230426" format="ixt:date-monthname-day-year-en">April 26, 2023</ix:nonNumeric></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_f89e0142257f4af681f9bdf07476506f" contextRef="c20230426to20230426">Eterna Therapeutics Inc.</ix:nonNumeric><br />
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">(Exact Name of Registrant as Specified in its Charter)</div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> <br />
        </span></div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 32.61%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_4b5e76b4e5a04b36ba80775ec0c10cb1" contextRef="c20230426to20230426" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 33.68%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_4bedcc66fc364ee0b2ca3f2cb2518a2c" contextRef="c20230426to20230426">001-11460</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 33%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_26a694fe55e04051b78a47732415bfe3" contextRef="c20230426to20230426">31-1103425</ix:nonNumeric><br />
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 32.61%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-style: italic;">(State or Other Jurisdiction of Incorporation)</div>
            </td>

    <td style="width: 33.68%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-style: italic;">(Commission File Number)</div>
            </td>

    <td style="width: 33%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-style: italic;">(IRS Employer Identification No.)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49.01%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_a5cc6e001e0b43fd8df665ac087d1d77" contextRef="c20230426to20230426">1035 Cambridge Street</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_9e589bee5d4d4026a2be724f38ecd6c2" contextRef="c20230426to20230426">Suite 18A</ix:nonNumeric></div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 49.01%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_8152fb48fa6d4ab2a432c3d17bc76b07" contextRef="c20230426to20230426">Cambridge</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_46d9ff36d5d340629e542aa6d2a4c73a" contextRef="c20230426to20230426">MA</ix:nonNumeric></div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_77bf0c51e17c4f15a19efc293bc38d1d" contextRef="c20230426to20230426">02141</ix:nonNumeric><br />
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.01%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-style: italic;">(Address of Principal Executive Offices)</div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-style: italic;">(Zip Code)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Registrant&#8217;s telephone number, including area code: <span style="font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_e9ac08469a8346ffa484f0ddd7699e98" contextRef="c20230426to20230426">212</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_40ab628d3a59422592295f99bc21e3a2" contextRef="c20230426to20230426">582-1199</ix:nonNumeric></span></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
        provisions:</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_38c1ba6f7f9e4c019e481cc0516c9094" contextRef="c20230426to20230426" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_36d72a350f3c439391c320e8b27b39a4" contextRef="c20230426to20230426" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_a4a65c2577b546988a00c834513e94e5" contextRef="c20230426to20230426" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
            </td>

  </tr>


</table>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_14f045b9ffa44a3cb0b11317f79201d4" contextRef="c20230426to20230426" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
              <div>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 41.3%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;">Title of each class</div>
            </td>

    <td style="width: 0.96%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 20%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;">Trading symbol</div>
            </td>

    <td style="width: 1%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 36.98%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;">Name of each exchange on which registered</div>
            </td>

  </tr>

  <tr>

    <td style="width: 41.3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_c81c97ce085640e49662f58445018acb" contextRef="c20230426to20230426">Common Stock, par value $0.005 per share</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 0.96%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 20%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_746a02a0ec4a4311b6d70237a6a40954" contextRef="c20230426to20230426">ERNA</ix:nonNumeric><br />
              </div>
            </td>

    <td style="width: 1%; vertical-align: middle; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 36.98%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_83c75c011c2048e7a3658c954cc835e1" contextRef="c20230426to20230426" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric><br />
              </div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities
        Exchange Act of 1934:</div>

      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_736770bbfc3f4377a14df6e737f271fc" contextRef="c20230426to20230426" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
        financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      </div>

      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 63pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 1.01</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Entry into a Material Definitive Agreement.</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <div>
        <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On April 26, 2023 (the &#8220;<span style="text-decoration: underline;">Closing Date</span>&#8221;), Eterna Therapeutics Inc., a Delaware corporation (the &#8220;<span style="text-decoration: underline;">Company</span>&#8221;), entered
          into an asset purchase agreement (the &#8220;<span style="text-decoration: underline;">Purchase Agreement</span>&#8221;), together with Exacis Biotherapeutics Inc. (&#8220;<span style="text-decoration: underline;">Exacis</span>&#8221;), the stockholders party thereto (the &#8220;<span style="text-decoration: underline;">Stockholders</span>&#8221;) and, with respect to specified provisions therein, Factor
          Bioscience Limited (&#8220;<span style="text-decoration: underline;">Factor</span>&#8221;).&#160; Pursuant to the Purchase Agreement, the Company acquired from Exacis substantially all of Exacis&#8217; intellectual property assets (the &#8220;<span style="text-decoration: underline;">Purchased Assets</span>&#8221;), including all of Exacis&#8217; right, title and
          interest in and to an exclusive license agreement by and between Exacis and Factor (the &#8220;<span style="text-decoration: underline;">Purchased License</span>&#8221;).&#160; The Company assumed none of Exacis&#8217; liabilities, other than liabilities under the Purchased License that accrue subsequent to
          the Closing Date.</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

        <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In consideration for the Purchased Assets, on the Closing Date, the Company issued to Exacis an aggregate of 69,343 shares of
          the Company&#8217;s common stock, par value $0.005 per share (&#8220;<span style="text-decoration: underline;">Common Stock</span>&#8221;), which shares are subject to a 12-month lockup, pursuant to which Exacis may not sell or otherwise transfer such shares.&#160; The Company additionally agreed to make the
          following contingent payments:&#160; (i) if, at any time during the three-year period commencing on the Closing Date and ending on the three-year anniversary of the Closing Date, the Company&#8217;s market capitalization equals or exceeds $100.0 million for
          at least ten consecutive trading days, then the Company will issue to Exacis a number of shares of Common Stock equal to (x) $2.0 million divided by (y) the quotient of $100.00 million divided by the number of the Company&#8217;s then issued and
          outstanding shares of Common Stock; (ii) if, at any time during the three-year period commencing on the Closing Date and ending on the three-year anniversary of the Closing Date, the Company&#8217;s market capitalization equals or exceeds $200.0
          million for at least ten consecutive trading days, then the Company will issue to Exacis a number of additional shares of Common Stock equal to (x) $2.0 million divided by (y) the quotient of $200.00 million divided by the number of the Company&#8217;s
          then issued and outstanding shares of Common Stock; and (iii) during the five-year period commencing on the Closing Date and ending on the five-year anniversary of the Closing Date (the &#8220;<span style="text-decoration: underline;">Five-Year Period</span>&#8221;), the Company will pay or deliver
          to Exacis 20% of all cash or other consideration (collectively, &#8220;<span style="text-decoration: underline;">License Consideration</span>&#8221;) actually received by the Company during the Five-Year Period from (i) third-party licensees or sublicensees of the intellectual property rights
          acquired by the Company from Exacis pursuant to the Purchase Agreement, or (ii) subject to certain exceptions, the sale of such intellectual property rights; provided, that the License Consideration shall not in any event exceed $45.0 million.</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

        <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Purchase Agreement contains customary representations and warranties of the parties thereto, and Exacis and the Stockholders
          have agreed to five-year non-competition and non-solicitation covenants in favor of the Company.</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">In the Purchase Agreement, Exacis represented to the Company that it is an &#8220;accredited investor&#8221;, as defined in Rule 501
          promulgated under the Securities Act of 1933, as amended (the &#8220;<span style="text-decoration: underline;">Securities Act</span>&#8221;), and the Company&#8217;s offer and sale of the shares of Common Stock described above have been made in reliance upon the exemptions from the registration
          requirements of the Securities Act pursuant to Section 4(a)(2) thereof and Rule 506(b) of Regulation D promulgated thereunder.</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

        <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Dr. Matthew Angel, the Company&#8217;s President and Chief Executive Officer, is the co-founder, President, CEO, and a director of
          Factor Bioscience Inc., which is the parent of Factor and a wholly owned subsidiary of Factor Bioscience LLC, the latter of which is the majority stockholder of Exacis.&#160; Dr. Gregory Fiore, one of the Company&#8217;s directors, is the Chief Executive
          Officer and a 10% stockholder of Exacis.&#160; The Purchase Agreement and the transactions contemplated thereby were approved by the audit committee of the Company&#8217;s board of directors (the &#8220;<span style="text-decoration: underline;">Board</span>&#8221;), as well as by all of the Company&#8217;s
          disinterested directors, comprising a majority of the Board.</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

        <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The foregoing description of the Purchase Agreement is only a summary and is qualified in its entirety by reference to the full
          text of the Purchase Agreement, a copy of which is filed herewith as Exhibit 10.1 and incorporated herein by reference.</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Purchase Agreement is filed with this Current Report on Form 8-K to provide securityholders with information regarding its
          terms.&#160; It is not intended to provide any other factual information about the Company, Exacis or any other party thereto.&#160; The representations, warranties and covenants contained in the Purchase Agreement were made solely for purposes of such
          agreement and as of specific dates, are solely for the benefit of the parties to the Purchase Agreement, may be subject to limitations agreed upon by the contracting parties, including being qualified by confidential disclosures made for the
          purpose of allocating contractual risk between the parties to the Purchase Agreement instead of establishing these matters as facts, and may be subject to standards of materiality applicable to the contracting parties that differ from those
          applicable to securityholders.&#160; Securityholders should not rely on the representations, warranties and covenants or any descriptions thereof as characterizations of the actual state of facts or condition of the Company, Exacis or any other party
          thereto.&#160; Moreover, information concerning the subject matter of the representations and warranties may change after the date of the Purchase Agreement, which subsequent information may or may not be fully reflected in the Company&#8217;s public
          disclosures, except to the extent required by law.</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      </div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 63pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 3.02</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="color: rgb(0, 0, 0); font-weight: bold;">Unregistered Sales of Equity Securities.</div>
              </td>

  </tr>


</table>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      </div>

      <div>
        <div style="text-align: justify; text-indent: 24.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The information contained in Item 1.01 of this Current Report on Form 8-K is incorporated by reference in this Item 3.02.</div>

        <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      </div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 63pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">
                <div style="color: rgb(0, 0, 0); font-weight: bold;">Financial Statements and Exhibits.</div>
              </td>

  </tr>


</table>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      </div>

      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;">


  <tr style="vertical-align: top;">

    <td style="vertical-align: top; width: 18pt;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">(d)</div>
              </td>

    <td style="align: left; vertical-align: top; width: auto;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold;">Exhibits.</div>
              </td>

  </tr>


</table>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 8%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit</div>
                <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number</div>
              </div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt; padding-bottom: 2px;">&#160;</td>

    <td style="width: 90%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-align: center;">
              <div>
                <div style="font-weight: bold;">Description</div>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;"><a href="brhc20052311_ex10-1.htm">10.1</a></div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: justify;">Asset Purchase Agreement, dated April 26, 2023, by and among Eterna Therapeutics Inc., Exacis Biotherapeutics Inc., the stockholders party thereto and, with respect to certain provisions, Factor Bioscience
                Limited.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 8%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: center;">104</div>
            </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 90%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: justify;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</div>
            </td>

  </tr>


</table>
      <div>
        <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
        </div>

      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

      </div>

      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURE</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto
        duly authorized.</div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49.65%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="2" style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; font-variant: small-caps;">Eterna Therapeutics Inc.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.65%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td colspan="2" style="vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 49.65%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">Dated: May 2<span style="color: rgb(0, 0, 0);">, 2023</span></div>
            </td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">By:</div>
            </td>

    <td style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">/s/ <span style="font-style: italic;">Matthew Angel</span></div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.65%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 47%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left;">Matthew Angel</div>
            </td>

  </tr>

  <tr>

    <td style="width: 49.65%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 3%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</td>

    <td style="width: 47%; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0);">Chief Executive Officer and President</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br />
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    </div>

  </div>

  <div><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>brhc20052311_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 23.3.2.5148
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div>
        <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit 10.1</div>
        <div>&#160;</div>
      </div>
      <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Execution Version</div>
      <div>
        <div><br>
        </div>
        <div>
          <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      </div>
      <div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
        </div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ASSET PURCHASE AGREEMENT</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
        </div>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Dated April 26, 2023</div>
      <div>&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">by and among</div>
      <div>&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Eterna Therapeutics Inc.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">as Buyer</div>
      <div>&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exacis Biotherapeutics Inc.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">as Seller</div>
      <div>&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">the Stockholders Party Hereto</div>
      <div>&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">and</div>
      <div>&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">solely for purposes of Section 6.01, Factor Bioscience Limited</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%LCR%1%%%-->
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>TABLE OF CONTENTS</u></div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="zd22e08661748423bab4d43cc5ac9cd73" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="vertical-align: top; background-color: rgb(204, 238, 255);" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">ARTICLE I PURCHASE AND SALE</div>
            </td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">1</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">1.01</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Purchase, Assignment and Sale of Purchased Assets</div>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">1</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">1.02</div>
            </td>
            <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Liabilities Assumed by Buyer</div>
            </td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">1</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">1.03</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Liabilities Not Assumed by Buyer</div>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">1</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">1.04</div>
            </td>
            <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Purchase Price; Issuance of Shares at Closing</div>
            </td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">2</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">1.05</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Lockup of Closing Date Shares</div>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">3</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; background-color: rgb(204, 238, 255);" colspan="2" rowspan="1">&#160;</td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top;" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">ARTICLE II CLOSING MATTERS</div>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">3</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">2.01</div>
            </td>
            <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Closing</div>
            </td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">3</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">2.02</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Deliveries by Seller</div>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">3</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">2.03</div>
            </td>
            <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Deliveries by Buyer</div>
            </td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">4</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">2.04</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Transfer of Purchased Assets</div>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">4</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; background-color: rgb(204, 238, 255);" colspan="2" rowspan="1">&#160;</td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top;" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">ARTICLE III REPRESENTATIONS AND WARRANTIES OF SELLER AND THE STOCKHOLDERS</div>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">4</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">3.01</div>
            </td>
            <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Organization</div>
            </td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">4</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">3.02</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Power and Authority</div>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">4</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">3.03</div>
            </td>
            <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">No Conflicts</div>
            </td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">5</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">3.04</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Governmental Approvals</div>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">5</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">3.05</div>
            </td>
            <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Corporate Matters; Indebtedness</div>
            </td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">5</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">3.06</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Purchased Assets; Title</div>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">5</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">3.07</div>
            </td>
            <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Compliance with Laws; Illegal Payments; Litigation</div>
            </td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">5</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">3.08</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Intellectual Property</div>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">6</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">3.09</div>
            </td>
            <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">No Brokers</div>
            </td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">7</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">3.10</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Securities Law Matters</div>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">7</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; background-color: rgb(204, 238, 255);" colspan="2" rowspan="1">&#160;</td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top;" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">ARTICLE IV REPRESENTATIONS AND WARRANTIES OF BUYER</div>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">8</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">4.01</div>
            </td>
            <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Organization</div>
            </td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">8</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">4.02</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Power and Authority; Issuance of Consideration Shares</div>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">8</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">4.03</div>
            </td>
            <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">No Conflicts</div>
            </td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">8</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">4.04</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Governmental Approvals</div>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">9</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">4.05</div>
            </td>
            <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">No Brokers</div>
            </td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">9</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top;" colspan="2" rowspan="1">&#160;</td>
            <td style="width: 6%; vertical-align: top;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top; background-color: rgb(204, 238, 255);" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">ARTICLE V INDEMNIFICATION</div>
            </td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">9</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">5.01</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Indemnification by Seller and the Stockholders</div>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">9</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">5.02</div>
            </td>
            <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Survival of Representations and Warranties</div>
            </td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">10<br>
              </div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">5.03</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Limitations on Seller&#8217;s and the Stockholders&#8217; Indemnification</div>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">10</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">5.04</div>
            </td>
            <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Indemnification by Buyer</div>
            </td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">10</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">5.05</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Knowledge and Investigation</div>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">10</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">5.06</div>
            </td>
            <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Indemnification Procedures</div>
            </td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">11</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">5.07</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Exclusive Remedies</div>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">11</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">5.08</div>
            </td>
            <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Right of Setoff</div>
            </td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">12</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top;" colspan="2" rowspan="1">&#160;</td>
            <td style="width: 6%; vertical-align: top;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top; background-color: rgb(204, 238, 255);" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">ARTICLE VI GENERAL</div>
            </td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">12</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">6.01</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Consent to Assignment</div>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">12</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">6.02</div>
            </td>
            <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Restrictive Covenants</div>
            </td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">12</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">6.03</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Investigation and Reliance</div>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">14</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: left;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">i</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%LCR%2%%%-->
      <table cellspacing="0" cellpadding="0" border="0" id="z197599affeea4dd0913abe6d1527ae6a" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">6.04</div>
            </td>
            <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Public Announcements</div>
            </td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">15</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">6.05</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Governing Law, Jurisdiction; Waiver of Jury Trial</div>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">15</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">6.06</div>
            </td>
            <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Entire Agreement</div>
            </td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">16</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">6.07</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Further Assurances</div>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">16</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">6.08</div>
            </td>
            <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Severability</div>
            </td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">16</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">6.09</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Amendment; Waiver</div>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">16</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">6.10</div>
            </td>
            <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Successors and Assigns; No Third-Party Beneficiaries</div>
            </td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">16</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">6.11</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Survival</div>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">16</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">6.12</div>
            </td>
            <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Interpretation; Rules of Construction</div>
            </td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">17</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">6.13</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Notices</div>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">17</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">6.14</div>
            </td>
            <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Fees and Expenses</div>
            </td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">18</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">6.15</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Schedules; Listed Documents</div>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">18</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">6.16</div>
            </td>
            <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Counterparts</div>
            </td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">18</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top;" colspan="2" rowspan="1">&#160;</td>
            <td style="width: 6%; vertical-align: top;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top; background-color: rgb(204, 238, 255);" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">ARTICLE VII DEFINITIONS</div>
            </td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">19</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">7.01</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Definitions</div>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">19</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">7.02</div>
            </td>
            <td style="width: 88%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Other Defined Terms</div>
            </td>
            <td style="width: 6%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">23</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">7.03</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Incorporation of Certain Terms From Purchased License</div>
            </td>
            <td style="width: 6%; vertical-align: top;">
              <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt;">23</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">EXHIBITS</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z5886d2bafec54fd8bdc629fcf40de981" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Exhibit A</div>
            </td>
            <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Pro Rata Shares</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Exhibit B</div>
            </td>
            <td style="width: 85%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Permitted Holders</div>
            </td>
          </tr>
          <tr>
            <td style="width: 15%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Exhibit C</div>
            </td>
            <td style="width: 85%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Exacis Convertible Notes</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SCHEDULES</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="za462e295379d42b3bdc2ab396f626caf" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 20%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Schedule 3.03</div>
            </td>
            <td style="width: 80%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">No Conflicts</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Schedule 3.08(a)(i)</div>
            </td>
            <td style="width: 80%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Copy of Purchased License</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Schedule 3.08(a)(ii)</div>
            </td>
            <td style="width: 80%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Owned Intellectual Property; Licensed Intellectual Property</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Schedule 3.08(a)(iii)</div>
            </td>
            <td style="width: 80%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Third-Party Interests in Purchased Assets</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Schedule 3.08(c)</div>
            </td>
            <td style="width: 80%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Licensed Products</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Schedule 3.08(d)</div>
            </td>
            <td style="width: 80%; vertical-align: top;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Licensee Edits and Licensee Targets</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">ii</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%1%%%-->
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>ASSET PURCHASE AGREEMENT</u></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">THIS ASSET PURCHASE AGREEMENT (this &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Agreement</u></font>&#8221;), dated as of April 26,
        2023, is entered into by and among Eterna Therapeutics Inc., a Delaware corporation (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Buyer</u></font>&#8221;), Exacis Biotherapeutics Inc., a Delaware corporation (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Seller</u></font>&#8221;), the stockholders named on signature pages hereto (together, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Stockholders</u></font>&#8221; and each
        individually, a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Stockholder</u></font>&#8221;), and, solely for purposes of <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6.01</u></font>, Factor Bioscience
        Limited, a company organized and existing under the laws of Ireland (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Factor</u></font>&#8221;).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, subject to the terms and conditions set forth herein, Seller desires to sell and assign to Buyer, and Buyer desires to purchase and acquire
        from Seller, all of Seller&#8217;s right, title and interest in and to that certain Exclusive License Agreement, dated as of November 4, 2020, by and between Factor and Seller (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Purchased




            License</u></font>&#8221;), together with the other Purchased Assets; and</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">WHEREAS, the Stockholders collectively own, beneficially or of record, 100% of the issued and outstanding capital stock of Seller and will
        materially benefit from the consummation of the Contemplated Transactions.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">NOW, THEREFORE, in consideration of the representations, warranties, covenants and agreements contained herein, the parties hereto, intending to be
        legally bound, hereby agree as follows:</div>
      <div>&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE I</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">PURCHASE AND SALE</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.01 &#160; &#160; &#160; <u>Purchase, Assignment and Sale of Purchased Assets</u></font>.&#160; On the
        date hereof, Seller hereby sells, assigns, transfers and conveys to Buyer and Buyer hereby purchases from Seller, subject to the terms and conditions of this Agreement, all of Seller&#8217;s right, title and interest in and to (i) the Purchased License
        and (ii) all Independent Inventions and other Intellectual Property owned by Seller (except for the Retained Intellectual Property), in each case of the immediately preceding clauses (i) and (ii), free and clear of all Liens (collectively, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Purchased Assets</u></font>&#8221;).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.02 &#160;&#160; &#160; <u>Liabilities Assumed by Buyer</u></font>.&#160; At Closing, Buyer shall
        assume from Seller only those Liabilities arising under the Purchased License to the extent accrued following the Closing Date (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Assumed Liabilities</u></font>&#8221;).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.03 &#160;&#160; &#160; <u>Liabilities Not Assumed by Buyer</u></font>.&#160; Notwithstanding anything
        in this Agreement to the contrary, other than the Assumed Liabilities, Seller shall retain and be responsible for all of Seller&#8217;s Liabilities, and neither Buyer nor any Affiliate of Buyer shall assume, or in any way be liable or responsible for any
        Liabilities of Seller or any Affiliate of Seller (collectively, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Excluded Liabilities</u></font>&#8221;).&#160; Without limiting the foregoing, the Excluded Liabilities shall include the
        following Liabilities of Seller or any Affiliate of Seller, whether or not such Liabilities are disclosed in any of the representations and warranties in this Agreement or on any Schedule with respect to such representations and warranties (for the
        elimination of doubt, such list is not exclusive):</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Purchase Agreement</u></font>.&#160; All Liabilities arising under, or relating to the execution and delivery of this Agreement and the consummation of the Contemplated Transactions;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Indebtedness</u></font>.&#160; All Liabilities for Indebtedness;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Excluded Contracts</u></font>.&#160; All Liabilities arising under all Contracts (other than the Purchased License, to the extent included as Assumed Liabilities);</font></div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">1</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Transaction Expenses</u></font>.&#160; All Liabilities of any kind or nature for fees and expenses referred to in <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6.14</u></font>;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Taxes</u></font>.&#160; All Liabilities for amounts due in respect of any Taxes of Seller; and</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(vi)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Affiliates</u></font>.&#160; All Liabilities to any present or former Affiliate or Stockholder of Seller.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.04 &#160; &#160; &#160;&#160; <u>Purchase Price; Issuance of Shares at Closing</u></font>.&#160; The
        aggregate purchase price for the Purchased Assets (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Purchase Price</u></font>&#8221;) shall comprise the following:</div>
      <div>&#160;</div>
      <div style="text-align: justify; margin-left: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">69,343 shares of Buyer Common Stock, issuable to
          Seller on the Closing Date (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Closing Date Shares</u></font>&#8221;);</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">if, at any time during the three-year period
          commencing on the Closing Date and ending on the three-year anniversary of the Closing Date, the Total Market Capitalization equals or exceeds $100.0 million for at least ten (10) consecutive Trading Days (such ten Trading Day period, a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Measurement Period</u></font>&#8221;), then Buyer shall, on or prior to the fifth (5<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>) Trading Day immediately following the last day of such Measurement Period, issue to Seller
          a number of shares of Buyer Common Stock (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>First Contingent Installment Shares</u></font>&#8221;) equal to (x) $2.0 million divided by (y) the quotient of $100.00 million divided by
          the number of Issued and Outstanding Shares of Buyer Common Stock as of the close of regular-session trading (i.e., ending at 4:00 p.m. Eastern Time) on the last Trading Day of such Measurement Period;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">if, at any time during the three-year period
          commencing on the Closing Date and ending on the three-year anniversary of the Closing Date, the Total Market Capitalization equals or exceeds $200.0 million during any Measurement Period, then Buyer shall, on or prior to the fifth (5<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>)
          Trading Day immediately following the last day of such Measurement Period, issue to Seller a number of additional shares of Buyer Common Stock (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Second Contingent Installment
              Shares</u></font>&#8221; and, together with the First Contingent Installment Shares, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Contingent Shares</u></font>&#8221;, and, together with the Closing Date Shares, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Consideration Shares</u></font>&#8221;)) equal to (x) $2.0 million divided by (y) the quotient of $200.00 million divided by the number of Issued and Outstanding Shares of Buyer Common Stock
          as of the close of regular session trading (i.e., ending at 4:00 p.m. Eastern Time) on the last Trading Day of such Measurement Period; and</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">During the five-year period commencing on the
          Closing Date and ending on the five-year anniversary of the Closing Date (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Five-Year Period</u></font>&#8221;), Buyer shall pay or deliver to Seller 20% of all cash or other
          consideration (collectively, &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>License Consideration</u></font>&#8221;) actually received by Buyer during the Five-Year Period from (i) third-party licensees or sublicensees of the
          intellectual property rights acquired by Buyer from Seller pursuant to this Agreement (including any such rights that, following termination of the Purchased License during the Five-Year Period, transfer to Buyer under the Factor-Eterna License
          Agreement) that are entered into by Buyer or an Affiliate thereof, or (ii) any Person (other than a subsidiary of Buyer) who (x) acquires from Buyer (pursuant to any sale or assignment) any of the intellectual property rights acquired by Buyer
          from Seller pursuant to this Agreement (including any such rights that, following termination of the Purchased License during the Five-Year Period, transfer to Buyer under the Factor-Eterna License Agreement) and (y) does not assume Buyer&#8217;s
          obligations under this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 1.04(d)</u></font> with respect to the payment of License Consideration to Seller in respect of such acquired intellectual property; <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>provided</u></font>, that the maximum aggregate amount payable to Seller pursuant to this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 1.04(d)</u></font>
          shall not exceed $45.0 million. Buyer shall provide, on or prior to the 15<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> day immediately following the end of each fiscal quarter during the Five-Year Period, quarterly reports to Seller detailing all License Consideration
          (commencing at the end of the first complete fiscal quarter of Buyer immediately following the Closing Date), and shall make all payments required with respect to the License Consideration under this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 1.04(d)</u></font> to Seller within thirty (30) days of the end of each such fiscal quarter. If all or a portion of any License Consideration is not payable to Buyer by the applicable licensee in cash, then Buyer
          shall deliver to Seller the foregoing 20% of such License Consideration in the same form (and combination thereof, as applicable) as received by Buyer, subject to applicable securities and other Laws.</font></div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">For the elimination of doubt, Buyer&#8217;s obligations to issue the First Contingent Installment Shares and the Second Contingent Installment Shares are independent of one
        another, and the Measurement Periods with respect to such obligations may overlap one another or run concurrently; <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>provided</u></font>, that Buyer shall not be obligated to issue
        either the First Contingent Installment Shares or the Second Contingent Installment Shares on more than one occasion.&#160; Additionally:&#160; (A) in the event of a Change of Control prior to the issuance of any Contingent Shares, in which Buyer is acquired
        at an equity valuation that equals or exceeds (x) $100.0 million, then Buyer shall at the closing of such acquisition make, or cause to be made, a cash payment to Seller in an amount equal to $2,000,000 or (y) $200.0 million, then Buyer shall at
        the closing of such acquisition make, or cause to be made, a cash payment to Seller in an amount equal to $4,000,000; and (B) in the event of a Change of Control subsequent to the issuance of the First Contingent Installment Shares but prior to the
        issuance of the Second Contingent Installment Shares, in which Buyer is acquired at an equity valuation that equals or exceeds $200.0 million, then Buyer shall at the closing of such acquisition make, or cause to be made, a cash payment to Seller
        in an amount equal to $2,000,000.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.05 &#160; &#160;&#160; <u>Lockup of Closing Date Shares</u></font>.&#160; During the period beginning
        on the Closing Date and ending at the close of business on the one-year anniversary of the Closing Date, neither Seller nor any Person acting on Seller&#8217;s behalf shall (i) offer, pledge, sell, contract to sell, sell any option or contract to
        purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any Closing Date Shares or (ii) enter into any hedging, swap or other agreement or
        transaction that transfers, in whole or in part, any of the economic consequences of ownership of the Closing Date Shares, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Closing Date Shares, in
        cash or otherwise. Seller acknowledges and agrees that the foregoing precludes the undersigned from engaging in any hedging or other transactions or arrangements (including, without limitation, any short sale or the purchase or sale of, or entry
        into, any put or call option, or combination thereof, forward, swap or any other derivative transaction or instrument, however described or defined) designed or intended, or which could reasonably be expected to lead to or result in, a sale or
        disposition (whether by the undersigned or someone other than the undersigned) or transfer of any economic consequences of ownership, in whole or in part, directly or indirectly, of any Closing Date Shares, whether any such transaction or
        arrangement (or instrument provided for thereunder) would be settled by delivery of Closing Date Shares, in cash or otherwise.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE II</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CLOSING MATTERS</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.01 &#160;&#160; &#160; <u>Closing</u></font>.&#160; Subject to the terms and conditions of this
        Agreement, the consummation of the Contemplated Transactions (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Closing</u></font>&#8221;) shall take place at the offices of Greenberg Traurig, P.A., 333 S.E. 2<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">nd</sup> Avenue,
        Suite 4400, Miami, Florida, 33133 at 10:00 a.m. (local time) (or pursuant to the electronic or other remote exchange of all executed documents and other closing deliverables required by <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 2.02</u></font> and <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 2.03</u></font>) on the date hereof (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Closing Date</u></font>&#8221;).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.02 &#160; &#160; &#160; <u>Deliveries by Seller</u></font>.&#160; At the Closing, Seller shall
        deliver, or cause to be delivered to Buyer:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">such assignments, transfers, consents and other
          documents and instruments as Buyer may request in order to complete and perfect the Contemplated Transactions, including the transfer of Purchased License;</font></div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">a certificate of the Secretary or an Assistant
          Secretary (or equivalent officer) of Seller certifying (i) that attached thereto are true and complete copies of all resolutions adopted by the board of directors of Seller authorizing the execution, delivery and performance of this Agreement and
          the Ancillary Agreements and the consummation of the transactions contemplated hereby and thereby, and that all such resolutions are in full force and effect and are all the resolutions adopted in connection with the transactions contemplated
          hereby and thereby, (ii) that attached thereto are true and complete copies of one or more written consents executed and delivered by all of the Stockholders, approving the consummation of the transactions contemplated hereby, and that all such
          consents are in full force and effect and are all of the approvals adopted by the Stockholders in connection with the transactions contemplated hereby, and (iii) the names and signatures of the officers of Seller authorized to execute and deliver
          this Agreement, all Ancillary Agreements, and all certificates and other instruments required to be executed and delivered by Seller hereunder; and</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">copies of the consents of 100% of the holders of
          the Exacis Convertible Notes, consenting to Seller entering into this agreement and the Ancillary Agreements and consummating the transactions contemplated hereby and thereby.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.03 &#160; &#160;&#160; <u>Deliveries by Buyer</u></font>.&#160; Buyer shall deliver, or cause to be
        delivered to Seller the Closing Date Shares, evidenced by irrevocable instructions to the Company&#8217;s transfer agent, instructing such agent to issue the Closing Date Shares in the name of Seller.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.04 &#160; &#160; &#160; <u>Transfer of Purchased Assets</u></font>.&#160; After the Closing, Seller
        and the Stockholders shall execute and deliver from time to time at the request of Buyer all such further instruments as may be required and as Buyer may request in order to vest in Buyer full and complete title to and the right to use the
        Purchased Assets, free and clear of all Liens.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE III</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">REPRESENTATIONS AND WARRANTIES</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">OF SELLER AND THE STOCKHOLDERS</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Seller and the Stockholders, jointly and severally, represent and warrant to Buyer as follows:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.01&#160;&#160; &#160;&#160; <u>Organization</u></font>.&#160; Seller is a corporation duly organized,
        validly existing and in good standing under the laws of the State of Delaware and has full corporate power and authority to own its properties and to carry on its business as currently conducted.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.02 &#160;&#160;&#160; <u>Power and Authority</u></font>.&#160; Each of Seller and each Stockholder has
        full power and authority to enter into this Agreement and the other agreements contemplated hereby, including any Ancillary Agreements to which it is a party, and to consummate the Contemplated Transactions.&#160; The execution and delivery by Seller of
        this Agreement and the Ancillary Agreements and the consummation by Seller of the Contemplated Transactions have been authorized by the Stockholders and by Seller&#8217;s board of directors, and no other authorization on the part of Seller, any
        Stockholder or any other Person is necessary to authorize the execution and delivery of this Agreement and the Ancillary Agreements or the consummation by Seller of the Contemplated Transactions.&#160; This Agreement and each Ancillary Agreement to
        which Seller or any Stockholder is a party has been or will be as of the Closing duly executed and delivered by Seller and by, or on behalf of, such Stockholder, as applicable, and each such agreement is, or will be at Closing, a valid and legally
        binding obligation of Seller or such Stockholder, as applicable, enforceable in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or other Laws affecting creditors&#8217; rights
        generally and by general principles of equity (regardless of whether enforcement is sought in a proceeding at law or in equity).</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.03 &#160; &#160; &#160; <u>No Conflicts</u></font>.&#160; Neither the execution, delivery and
        performance of this Agreement or the Ancillary Agreements, nor the consummation of the Contemplated Transactions, will (a) constitute or cause a breach, default or violation (i) of the organizational documents of Seller or any Stockholder or (ii)
        the Purchased License, (b) cause a Lien to attach to the Purchased Assets, (c) except as set forth on <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Schedule 3.03</u></font>, result in the acceleration of or the right to
        accelerate any obligation under or the termination of or the right to terminate the Purchased License, (d) require a consent of any Person to prevent such breach, default, violation, Lien, acceleration, right or termination or (e) conflict with,
        result in a breach of or violate any Law.&#160; Except as set forth on <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Schedule 3.03</u></font>, no approval or consent of any Person is needed in order that (i) the Purchased License
        continues in full force and effect immediately following the consummation of the Contemplated Transactions and (ii) the Purchased License can be assigned to and assumed by Buyer and remain in full force and effect after such assignment and
        assumption.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.04 &#160;&#160; </font><u>Governmental



            Approvals</u></font>.&#160; No action by (including any authorization, consent or approval), or in respect of, or filing with, any Governmental Authority is necessary to authorize the execution and delivery of this Agreement and the Ancillary
        Agreements by Seller or any Stockholder or the consummation of the Contemplated Transactions.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.05 &#160; &#160;&#160; </font><u>Corporate



            Matters; Indebtedness</u></font>.&#160; Seller delivered to Buyer:&#160; (i) a true, correct and complete copy of the organizational documents of Seller; (ii) a true, correct and complete list of the names of the officers of Seller; and (iii) a true,
        correct and complete list of all outstanding Equity Interests of Seller, including the holders thereof.&#160; Except for the Exacis Convertible Notes and trade credit (including amounts payable to consultants) incurred in the ordinary course of
        business, Seller has no Indebtedness.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.06 &#160; &#160;&#160; </font><u>Purchased



            Assets; Title</u></font>.&#160; Seller has good, marketable and exclusive title to the Purchased Assets, free and clear of all Liens.&#160; Seller is transferring to Buyer or its assignee good and unencumbered marketable title to the Purchased Assets at
        Closing, free and clear of all Liens.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.07 &#160; &#160; &#160; </font><u>Compliance



            with Laws; Illegal Payments; Litigation</u></font>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Since its inception, Seller has been in compliance,
          in all material respects, with all Laws.&#160; Seller has not been charged with, received any written notice of or been under investigation with respect to, any alleged material default under, material violation of or material nonconformity with, any
          Law or any of Seller&#8217;s leases, Contracts or policies, or any restriction, condition, covenant or commitment (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Restriction</u></font>&#8221;) relating to or concerning Seller, its
          business or the Purchased Assets, including all Laws and Restrictions regarding (i) employment and employment practices, unemployment compensation, worker&#8217;s compensation, terms and conditions of employment and wages and hours, discrimination in
          employment, or unfair labor practices, (ii) employee benefit plans, policies, arrangements, commitments or agreements, including the delivery of all notices, reports, descriptions and other communications to participants required by such Laws, or
          (iii) corrupt practices, anti-bribery, anti-kickback and other similar Laws.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">No Affiliate, employee or other Person acting on
          behalf of Seller directly or indirectly, has (i) made any contribution, gift, bribe, rebate, payoff, influence payment, kickback, or other payment to any Person, private or public, regardless of form, whether in money, property, or services for
          any illegal purpose or (ii) established or maintained any fund or asset for the benefit of Seller that has not been recorded in the books and records of Seller.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Seller is not subject to any judicial, governmental
          or administrative order, judgment or decree (other than those applicable to businesses or industries as a whole).&#160; No litigation of any kind or nature or governmental or administrative investigation or proceeding to which Seller is or may be a
          party, or by which any of its assets may be bound, is now pending or, to Seller&#8217; Knowledge, threatened, and no claim which has not ripened into litigation or other such proceeding has been made or to Seller&#8217; Knowledge, threatened against Seller
          within the past five (5) years.</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.08 &#160; &#160; &#160; </font><u>Intellectual



            Property</u></font>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160; &#160; &#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Schedule 3.08(a)(i)</u></font> includes a true, complete and correct copy of the Purchased License, including all schedules, exhibits, amendments, waivers and any notices given or received by Seller with respect thereto. Except
          as otherwise set forth in <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Schedule 3.08(a)(ii)</u></font> and except for the Retained Intellectual Property, Seller does not own any Intellectual Property, including, without
          limitation, any Independent Invention, and Seller does not have any licenses to use any Intellectual Property owned by any third party other than the Purchased License. Except as set forth in <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Schedule 3.08(a)(iii)</u></font>, no Stockholder, director, officer, employee or independent contractor of Seller or any other Person has any current or contingent right, title or interest, or any license, sublicense, option, right
          of first offer, right of first refusal or other right to acquire any right, title or interest, with respect to the Purchased License or any of the other Purchased Assets.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">The Purchased License and, to Seller&#8217;s Knowledge,
          the Intellectual Property licensed to Seller, as well as Seller rights, title and interests with respect to the Intellectual Property listed in <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Schedule 3.08(a)(ii)</u></font> are
          valid and enforceable.&#160; There are no events, circumstances, claims or defenses that would invalidate, impair or preclude enforcement of any of the Intellectual Property owned by Seller or, to Seller&#8217;s Knowledge, licensed to Seller, forming part
          of the Purchased Assets, including misuse, laches, acquiescence, statute of limitations, statutory bars, abandonment or fraud. There have not been any claims or Actions against Seller, or to Seller&#8217;s Knowledge, Factor or any of Factor&#8217;s
          Affiliates, and there are no pending or threatened claims or Actions against Seller, or to Seller&#8217;s Knowledge, Factor or any of Factors&#8217; Affiliates, in either case contesting the validity, ownership, enforceability, use or right to use or grant
          licenses to use any of the Intellectual Property licensed under the Purchased License or any of the other Purchased Assets, and to Seller&#8217;s Knowledge, there is no reasonable basis for any such claim.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Purchased License is in full force and effect
          and neither Seller nor, to Seller&#8217;s Knowledge, Factor, is in breach or violation of any provision thereof. Seller has not provided or received any notice of breach or termination, or of any intention or threat to terminate the Purchased License.&#160;
          All payments and issuances of stock required to be made and all actions required to be taken by Seller under the Purchased License prior to the Closing have been made and taken. Except as set forth in <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Schedule 3.08(c)</u></font>, Seller has not undertaken any development or commercialization of any Licensed Products. To Seller&#8217;s Knowledge, the Intellectual Property licensed under the Purchased License is sufficient for
          the use of the Licensed Technology for development and commercialization of Licensed Products in the Field without a requirement to obtain any additional license or other rights from Factor or any other Person with respect to any Intellectual
          Property.&#160; There have been no claims or Actions by any Person with respect to the Purchased License. There have been no amendments, waivers, releases, assignments, joinders, supplements, addenda with respect to the Purchased License, or any
          additional agreements entered into by Seller with respect to the Purchased License, nor has Seller published any scientific findings or other reports or publications related to the Licensed Technology.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Schedule 3.08(d)</u></font> sets forth a complete and correct list of all Licensee Edits and Licensee Targets that have been selected by Seller pursuant to Section 4.1 of the Purchased License, as well as any replacements with
          respect thereto that Seller has requested and a complete and correct list of any Licensee Edits or Licensee Targets that remain available for selection pursuant to Section 4.1 of the Purchased License.</font></div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> <br>
        </font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">The use or other exploitation of the Purchased
          Assets by Seller has not infringed, misappropriated or otherwise violated, and does not infringe, misappropriate or otherwise violate, any Intellectual Property or other rights of any other Person, and, to Seller&#8217;s Knowledge, the continued use
          and other exploitation of the Intellectual Property licensed under the Purchased License in accordance with the terms of the Purchased License and use and exploitation of the other Purchased Assets will not infringe, misappropriate or otherwise
          violate any Intellectual Property or other rights of any other Person.&#160; Seller has not received any threats or notices regarding any of the foregoing (including any demands or offers to license any Intellectual Property from any other Person). To
          Seller&#8217;s Knowledge, none of the Intellectual Property forming part of the Purchased Assets is subject to any outstanding consent, settlement, decree, order, injunction, judgment or ruling restricting the use or ownership thereof. To Seller&#8217;s
          Knowledge, no Person is infringing any of the Intellectual Property licensed under the Purchased License or any other Intellectual Property forming part of the Purchased Assets.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Seller has taken all actions necessary to maintain
          and protect the secrecy, confidentiality and value of the Trade Secrets (if any) forming part of the Purchased Assets.&#160; No such Trade Secrets have been or are authorized by Seller to be disclosed to any Person other than to employees of Seller
          that need to know same and who have executed and delivered a written agreement obligating them to maintain the confidentiality thereof and not use same other than as necessary for activities in connection with and in furtherance of Seller&#8217;s
          business.&#160; Each current and former employee, consultant and contractor of Seller, and each other Person that has authored, developed or otherwise created any Intellectual Property for or on behalf of Seller, has entered into agreements with
          Seller pursuant to which he, she or it (i) agrees to maintain the confidentiality of and otherwise protect the Trade Secrets forming part of the Purchased Assets and (ii) assigns to Seller, via a present assignment, all Intellectual Property
          authored, developed or otherwise created in the course of his, her or its employment or other relationship with Seller, without further consideration or any restrictions or obligations use or ownership of such Intellectual Property whatsoever,
          and such agreements are valid and enforceable in accordance with their terms.&#160; To Seller&#8217;s Knowledge, no Person has breached any such agreement.&#160; Seller has provided to Buyer copies of all such agreements.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.09 &#160; &#160;&#160; </font><u>No



            Brokers</u></font>.&#160; None of Seller or any Stockholder has Liability of any kind to, or is subject to any claim of, any broker, finder or agent in connection with the Contemplated Transactions.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.10 &#160; &#160; &#160; </font><u>Securities



            Law Matters</u></font>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">The Consideration Shares issuable to Seller in
          accordance with the terms of this Agreement are being acquired by Seller for Seller&#8217;s own account and not with a view to, or intention of, distribution thereof in violation of the Securities Act, or any applicable state securities laws, and such
          Consideration Shares will not be disposed of by Seller in contravention of the Securities Act or any applicable state securities laws.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Seller is an &#8220;accredited investor&#8221; as defined in
          Rule 501(a) under the Securities Act, is sophisticated in financial matters and is able to evaluate the risks and benefits of the investment in the Consideration Shares and make an informed investment decision.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160; &#160; &#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Seller has had an opportunity to ask questions and
          receive answers concerning Buyer and the Consideration Shares and has had full access to such other information concerning Buyer and the Consideration Shares as Seller has requested or which has been filed by Buyer with the SEC.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font>&#160;&#160;&#160; &#160; &#160; &#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Seller has discussed with and relied upon the
          advice of its independent legal counsel, tax and financial advisors with regard to the meaning and legal consequences of Seller&#8217;s representations and warranties contained herein and the considerations involved in making an investment in the
          Consideration Shares, and Seller understands that Buyer is relying on Seller&#8217;s representations set forth herein in respect of the offer and sale of the Consideration Shares pursuant to the terms of this Agreement.</font></div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Seller acknowledges that the Consideration Shares
          issuable pursuant to the terms of this Agreement are &#8220;restricted securities&#8221; as defined in Rule 144 promulgated under the Securities Act, are not registered under the Securities Act or any applicable state securities laws and are being issued by
          Buyer to Seller in reliance upon exemptions from registration contained in, or promulgated under, the Securities Act.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Seller understands that the Consideration Shares
          acquired (or that may be acquired) pursuant to this Agreement have not been registered under the Securities Act or applicable state securities laws and such shares may therefore not be sold, transferred, pledged, or otherwise disposed of unless
          subsequently so registered or, in the opinion of counsel that registration under the Securities Act or any applicable state securities laws is not required.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)</font>&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Legends.&#160; It is understood that the certificates (if
          any) evidencing the Consideration Shares shall contain the legend in substantially the following form (together with any other legend required by applicable Law):</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.&#160; THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR
        HYPOTHECATED IN THE ABSENCE OF A REGISTRATION STATEMENT IN EFFECT WITH RESPECT TO THE SECURITIES UNDER SUCH ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED OR UNLESS SOLD PURSUANT TO RULE
        144 OF SUCH ACT.&#8221;</div>
      <div>&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE IV</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">REPRESENTATIONS AND WARRANTIES</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">OF BUYER</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Buyer represents and warrants to Seller as follows:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.01&#160;&#160;&#160;&#160;&#160; <u>Organization</u></font>.&#160; Buyer is corporation duly organized, validly
        existing and in good standing under the laws of the State of Delaware, and has full corporate power and authority to own its properties and to carry on its business as now conducted.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.02 &#160; &#160; </font><u>Power



            and Authority; Issuance of Consideration Shares</u></font>.&#160; Buyer has full power and authority to enter into this Agreement and the Ancillary Agreements to which it is a party, and to consummate the Contemplated Transactions.&#160; This Agreement
        and each Ancillary Agreement to which Buyer is a party has been duly executed and delivered by Buyer, and each such agreement is a valid and legally binding obligation of Buyer, enforceable in accordance with its terms, except as such
        enforceability may be limited by bankruptcy, insolvency, reorganization, moratorium or other Laws affecting creditors&#8217; rights generally and by general principles of equity (regardless of whether enforcement is sought in a proceeding at law or in
        equity).&#160; The Consideration Shares, when issued and delivered to Seller as provided herein, will be duly authorized, validly issued, fully paid and nonassessable and will be issued free and clear of any Lien (other than as arising under applicable
        securities laws and Liens created by Seller).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.03 &#160; &#160; &#160;</font> <u>No



            Conflicts</u></font>.&#160; Neither the execution, delivery and performance of this Agreement or the Ancillary Agreements, nor the consummation of the Contemplated Transactions, will (a) constitute or cause a breach, default or violation of the
        charter documents or by-laws of Buyer, any Contract, lease, permit, approval or agreement to which Buyer is a party or any other covenant or obligation binding upon Buyer or affecting any of Buyer&#8217;s assets or properties, (b) cause a Lien to attach
        to any of Buyer&#8217;s assets or properties, (c) result in the acceleration of or the right to accelerate any obligation under or the termination of or the right to terminate any such Contract, lease, permit, approval or agreement to which Buyer is a
        party, or (d) require a consent of any Person to prevent such breach, default, violation, Lien, acceleration, right or termination.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.04 &#160; &#160; &#160;</font> <u>Governmental



            Approvals</u></font>.&#160; Except for such filings or approvals as shall have been made and obtained on or prior to the Closing Date, no approval of or filing with any Governmental Authority is necessary to authorize the execution and delivery of
        this Agreement and the Ancillary Agreements by Buyer or the consummation of the Contemplated Transactions by Buyer.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.05 &#160; &#160; &#160;</font> <u>No



            Brokers</u></font>.&#160; Buyer has no Liability of any kind to any broker, finder or agent with respect to the Contemplated Transactions.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE V</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">INDEMNIFICATION</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.01 &#160; &#160;&#160; <u>Indemnification by Seller and the Stockholders</u></font>.&#160; (i) Seller
        and (ii) the Stockholders, severally (and not jointly with any other Stockholder) in accordance with each Stockholder&#8217;s Pro Rata Share, shall indemnify, defend and hold harmless Buyer, Buyer&#8217;s Subsidiaries and other Affiliates and their respective
        officers, directors, managers, employees, attorneys, agents and stockholders (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Buyer Indemnified Parties</u></font>&#8221;) from, against and with respect to any claim, Action,
        Liability, obligation, loss, damage, assessment, judgment, settlement, dues, penalties, interest, fines, Taxes, costs (including costs of investigation, defense and enforcement of this Agreement), expenses, attorneys&#8217; and accountants&#8217; fees, and
        costs and expenses incurred in investigating, preparing, defending against or prosecuting any Action (individually, a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Loss</u></font>&#8221; and collectively, &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Losses</u></font>&#8221;), (and without giving effect to any Tax benefit to the indemnified party), arising out of or in any manner incident, relating or attributable to:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">any breach of, or inaccuracy or incompleteness in,
          any representation or warranty made by Seller or any Stockholder contained in this Agreement, the Ancillary Agreements or in any certificate, instrument of transfer or other document or agreement executed by Seller or any Stockholder in
          connection with this Agreement or otherwise made or given in connection with this Agreement;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">any failure by Seller or any Stockholder to perform
          or observe, or to have performed or observed, in full, any covenant or agreement to be performed or observed by any of them under this Agreement or under any certificates or other documents or agreements executed by any of them in connection with
          this Agreement;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">the Excluded Liabilities, including any claim or
          Action arising out of or in any manner incident, relating or attributable to the Excluded Liabilities; or</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">all federal, state, local and foreign Tax liability,
          including any related penalties, interest charges and fees, of Seller or any Stockholder.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">For purposes of clarification, Seller hereby agrees not to dissolve or liquidate prior to the fifth (5<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup>) anniversary of the Closing Date.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.02 &#160; &#160; &#160;</font> <u>Survival



            of Representations and Warranties</u></font>.&#160; The representations and warranties of the parties contained in this Agreement shall continue in full force and effect after the Closing Date until the eighteen (18) month anniversary of the Closing
        Date, except that the representations and warranties:&#160; set forth in <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 3.01</u></font>, <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 3.02</u></font>,
        clause (a)(i) of <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 3.03</u></font>, <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 3.06</u></font>, <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 3.09</u></font>, <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 4.01</u></font> and <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 4.02</u></font> shall
        survive until the date that is thirty (30) days after the expiration of the applicable statute of limitations.&#160; Any claims brought under this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>ARTICLE V</u></font> with respect to
        Losses pursuant to <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 5.01(a)</u></font> or clause (a) of <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 5.04</u></font> must be brought by written
        notice delivered by the Indemnified Party to the Indemnifying Party in accordance with <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6.13</u></font> (Notices) prior to the expiration of the applicable survival period; <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>provided</u></font>, that any such claim brought prior to the expiration of the applicable survival period shall survive until final resolution of such claim.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.03 &#160; &#160; &#160;</font> <u>Limitations



            on Seller&#8217;s and the Stockholders&#8217; Indemnification</u></font>.&#160; Seller and the Stockholders shall have no obligation to indemnify the Buyer Indemnified Parties for any Losses pursuant to <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 5.01(a)</u></font> until such time as such Losses, in the aggregate, exceed $100,000 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Deductible</u></font>&#8221;), at which point Seller and the Stockholders
        shall be liable for the amount of such Losses in excess of the Deductible (in the case of each Stockholder, in amount equal to such Stockholder&#8217;s Pro Rata Share of such excess). The maximum aggregate amount of indemnifiable Losses for which Seller
        and the Stockholders shall be liable pursuant to <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 5.01(a)</u></font> shall be equal to 25% of the Purchase Price (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Indemnity Cap</u></font>&#8221;); <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>provided</u></font>, that solely for purposes of calculating the Indemnity Cap, the following shall apply: (i) only amounts actually
        received by Seller pursuant to <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 1.04(d)</u></font> shall be taken into account; (ii) the value of any Closing Date Shares or Contingent Shares (if any) shall be equal to the
        lesser of (x) the value of such shares on the applicable date of issuance of such shares by the Company in accordance with <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 1.04</u></font> and (y) the value of such shares
        on the first date on which such shares are eligible to be sold by Seller in accordance with Rule 144 promulgated under the Securities Act and in compliance with the transfer restrictions set forth in <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 1.05</u></font>; and (iii) solely with respect to the Stockholders (and, for the elimination of doubt, not with respect to Seller), only amounts received by Seller pursuant to Section 1.04 (in the case of Closing
        Date Shares or Contingent Shares, valued as set forth in the immediately preceding clause (ii)) in excess of $5.0 million shall be taken into account; <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>provided</u></font>, <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>however</u></font>, that neither the Deductible nor the Indemnity Cap shall apply to any claim pursuant to <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section
            5.01(a)</u></font> with respect to any inaccuracy in, or breach of, any representation or warranty made in <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 3.01</u></font>, <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 3.02</u></font>, clause (a)(i) of <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 3.03</u></font>, <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 3.06</u></font>
        or <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 3.09</u></font> or in the case of fraud.&#160; For the avoidance doubt, neither the Deductible nor the Indemnity Cap shall apply to any claims for indemnification pursuant to
        <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Sections 5.01(b)</u></font>, <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>5.01(c)</u></font> or <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>5.01(d)</u></font>.
        Notwithstanding anything contained herein to the contrary, Seller shall not be liable to any Buyer Indemnified Party under this Agreement or any Ancillary Agreement for any punitive damages, except and to the extent such punitive damages are
        awarded to a third party.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.04&#160; &#160; &#160;</font> <u>Indemnification



            by Buyer</u></font>.&#160; Buyer shall indemnify, defend and hold harmless Seller and the Stockholders, and their respective officers, managers, employees, attorneys and agents (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Seller



            Indemnified Parties</u></font>&#8221;) from, against and with respect to any Losses, of any kind or character, arising out of or in any manner incident, relating or attributable to (a) any inaccuracy or incompleteness in any representation or breach
        of any warranty of Buyer contained in this Agreement or in the Ancillary Agreements or any certificate, instrument of transfer or other document or agreement executed by Buyer pursuant to this Agreement, (b) any failure by Buyer to perform or
        observe, or to have performed or observed, in full, any covenant or agreement to be performed or observed by Buyer under this Agreement or under any certificates or other documents or agreements executed by Buyer pursuant to this Agreement or (c)
        the Assumed Liabilities.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.05 &#160;&#160; &#160;</font> <u>Knowledge



            and Investigation</u></font>.&#160; The right of any Buyer Indemnified Party or Seller Indemnified Party to indemnification pursuant to this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>ARTICLE V</u></font> will not be affected
        by any investigation conducted or knowledge acquired (or capable of being acquired) at any time, whether before or after the execution and delivery of this Agreement or the Closing, with respect to the accuracy of any representation or warranty,
        performance of or compliance with any covenant or agreement referred to in <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Sections 5.01</u></font> or <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>5.04</u></font>
        or otherwise.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">10</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.06 &#160; &#160; &#160;</font> <u>Indemnification



            Procedures</u></font>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Any party making a claim for indemnification under
          <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>ARTICLE V</u></font> hereof (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Indemnified Party</u></font>&#8221;) will notify the party from whom indemnification
          is claimed (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Indemnifying Party</u></font>&#8221;) of the claim in writing promptly after receiving written notice of any Action or claim against it (if by a third party) or
          discovering the liability, obligation or facts giving rise to such claim for indemnification.&#160; The failure to so notify the Indemnifying Party will not relieve the Indemnifying Party of its obligations under <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>ARTICLE V</u></font>, except to the extent that such failure actually materially prejudices the Indemnifying Party.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">With respect to any third-party claim which gives
          rise or is alleged to give rise to a claim for indemnity under <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>ARTICLE V</u></font>, except for any claim relating to Taxes or any alleged violation of criminal Law, the
          Indemnifying Party, at its option and own expense, will be entitled to assume responsibility for and control the defense of such claim and to appoint a competent and reputable counsel reasonably acceptable to the Indemnified Party to act as lead
          counsel of such defense.&#160; The Indemnifying Party shall thereafter consult with the Indemnified Party upon the Indemnified Party&#8217;s reasonable request for such consultation, from time to time, with respect to such claim, suit, action or proceeding.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">An Indemnifying Party&#8217;s rights under <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>ARTICLE V</u></font> will be subject to the following additional limitations:&#160; with respect to any claim the defense of which the Indemnifying Party has assumed, the Indemnified Party
          will be entitled to participate in the defense of such claim and to employ counsel of its choice for such purpose, and the fees and expenses of such separate counsel will be borne solely by the Indemnified Party; if the Indemnifying Party assumes
          control of the defense of any such claim, then the Indemnifying Party will obtain the prior written consent of the Indemnified Party before entering into any settlement of such claim, if such settlement does not expressly and unconditionally
          release the Indemnified Party from all Losses and obligations with respect to such claim with prejudice; and, if the Indemnifying Party assumes control of the defense of any such claim, then the Indemnifying Party and its counsel will proceed
          diligently and in good faith with respect thereto.&#160; If the Indemnifying Party has the right to, but does not, assume control of the defense of any claim in accordance with this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>ARTICLE




              V</u></font>, then the Indemnifying Party may nonetheless participate (at its own expense) in the defense of such claim and the Indemnified Party will consult with the Indemnifying Party in respect of such defense.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Any amount owing by any Person pursuant to this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>ARTICLE V</u></font> shall be paid, by wire transfer of immediately available funds, within two (2) Business Days after mutual agreement of the parties or a final judicial adjudication
          of such amount.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.07&#160; &#160; &#160; &#160;</font> <u>Exclusive



            Remedies</u></font>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font> &#160; &#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">The rights of each Indemnified Party under this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>ARTICLE V</u></font> are cumulative, and each Indemnified Party will have the right in any particular circumstance, in its sole discretion, to enforce any provision of this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>ARTICLE V</u></font> without regard to the availability of a remedy under any other provision of this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>ARTICLE V</u></font>.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Except with respect to claims arising from fraud or
          claims for equitable relief, the parties acknowledge and agree that their sole and exclusive remedy with respect to any and all claims for any breach of any representation, warranty, covenant, agreement or obligation set forth herein, shall be
          pursuant to the indemnification provisions set forth in this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>ARTICLE V</u></font>.&#160; Notwithstanding the foregoing, the provisions of this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>ARTICLE V</u></font> shall not affect the rights of any party hereto against any third party (including a third party whose claim against a party hereto is the basis of a claim for indemnification) and shall
          not inure to the benefit of any third party.</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">11</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.08 &#160;&#160; &#160;</font> <u>Right



            of Setoff</u></font>.&#160; Upon Buyer&#8217;s notice to Seller specifying in reasonable detail the basis therefore, Buyer may setoff any amount to which it may be entitled from Seller against the License Consideration.&#160; The exercise of such right of
        setoff by Buyer in good faith, whether or not ultimately determined to be justified, will not constitute an event of default under this Agreement or any other agreement between Buyer or any of its Affiliates and Seller, any Stockholder (if
        applicable) or any of their respective Affiliates.&#160; Neither the exercise nor failure to exercise such right of setoff will constitute an election of remedies or limit Buyer in any manner in the enforcement of any other remedies that may be
        available to it.&#160; Notwithstanding the foregoing, if the Buyer sets off an amount pursuant to this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 5.08</u></font> and it is later finally mutually determined by the parties
        or pursuant to <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6.04</u></font> that such setoff amount was in excess of the amount which Seller was required to indemnify Buyer, then Buyer shall pay interest to Seller on
        such excess amount, for the period commencing on the date on which Buyer set off such amount to, but not including, the date on which Buyer pays such excess amount to Seller, at the Prime Rate, as published by the Wall Street Journal on the date
        such setoff was made, plus two percent (2%).</div>
      <div>&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE VI</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">GENERAL</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">6.01 &#160; &#160;&#160; <u>Consent to Assignment</u></font>.&#160; In accordance with Section 11.2 of
        the Purchased License, Factor hereby consents to the purchase, sale and assignment of the Purchased License effected hereunder.&#160; Buyer shall, as of the date of this Agreement, assume, and be bound by all obligations of Seller under the Purchased
        License (provided that, for avoidance of doubt, such assumption of obligations under the Purchased License shall not eliminate Seller&#8217;s and the Stockholders&#8217; obligations to Buyer or any other Buyer Indemnified Parties, or Buyer&#8217;s or any other Buyer
        Indemnified Party&#8217;s rights and remedies against Seller and the Stockholders, hereunder with respect to any Action, Liability or Losses that are not Assumed Liabilities).&#160; Factor and Buyer agree that in the event the Purchased License is terminated
        and&#160; the Exclusive License Agreement between Factor and Buyer dated February 20, 2023 (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Factor-Eterna License Agreement</u></font>&#8221;) is still in effect as of the effective date of
        such termination, notwithstanding anything to the contrary in the Factor-Eterna License Agreement, all rights granted under the Purchased License under the Licensed Technology, the Auxiliary Technologies, and the Auxiliary Technology Patents to
        Exploit Licensed Products in the Territory in the Field, and rights related thereto (each, as defined in the Purchased License) (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Exacis Granted Rights</u></font>&#8221;) shall revert back
        to Factor, subject to the terms of the Purchased License, and Buyer shall not have any rights under the Factor-Eterna License Agreement with respect to such Exacis Granted Rights.&#160; Factor acknowledges and agrees that, as of the date of this
        Agreement:&#160; (i) there are no amounts due and payable to Factor under the Purchased License that have not been satisfied on or prior to the date hereof; (ii) the Purchased License is, and will be following Closing, in full force and effect; and
        (iii) Seller is not in default under the Purchased License nor has any event occurred which, with the passage of time, would constitute a default under the Purchased License.&#160; Buyer, Seller and Factor agree that, subject to the terms of this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6.01</u></font>, all requirements under Section 11.2 of the Purchased License for the Purchased License to be validly assigned by Seller to Buyer have been satisfied.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">6.02 &#160; &#160; &#160;</font> <u>Restrictive



            Covenants</u></font>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Noncompetition</u></font>.&#160; Seller and each Stockholder on his or its own behalf, and on behalf of each of his or its Affiliates, covenants that, from the Closing Date through the five (5) year anniversary of the Closing Date,
          Seller will not, for its own account, jointly with another or for or on behalf of any Person, directly or indirectly, anywhere within the world (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Territory</u></font>&#8221;):</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">engage in the business intended to be conducted by
          Seller with respect to the Purchased Assets, including the development and commercial exploitation of cell therapy products for the treatment of cancer (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Business</u></font>&#8221;)
          or own, manage or control, or become engaged by or serve as a shareholder, stockholder, consultant or representative of, any Person, business or enterprise that competes directly or indirectly with Buyer or any of its Affiliates in the Business
          (a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Competitive Business</u></font>&#8221;); <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>provided</u></font>, <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>however</u></font>, that Seller may passively hold up to one percent (1%) of the outstanding publicly-traded securities of a Person engaged in a Competitive Business for investment purposes only;</font></div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">12</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">recruit, induce, solicit or employ, or in any
          manner attempt to recruit, induce, solicit or employ, any Person that is at such time, or during the previous six-month period was, an employee, independent contractor or consultant of Buyer;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">solicit any Person that is at such time, or
          during the previous twelve-month period was, (A) a customer, supplier or business associate of either Buyer or (B) a Person from whom Seller solicited business or with whom Seller discussed a potential business relationship, in each case, for the
          purpose of offering or providing services or products which are related to the Business or competitive with services or products provided by the Buyer;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">cause or seek to cause to be terminated or
          adversely affected, or otherwise interfere with, any Contract of any kind applicable to the Business or the Buyer or from which it or they benefit;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">seek to interfere with or adversely affect the
          ongoing relationships between the Buyer, on the one hand, and its suppliers, customers and professional and business contacts, on the other hand; or</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(vi)</font>&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">make any negative, derogatory or disparaging
          statements or communications regarding the Business, Buyer or its Affiliates or employees.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Acknowledgement</u></font>.&#160; Each of Seller and each Stockholder acknowledges that Buyer conducts, is capable of conducting and plans to conduct, the Business throughout the Territory; and that they each are intimately familiar
          with Seller&#8217;s and the Business&#8217; Trade Secrets, Confidential Information and employee, customer and supplier relationships.&#160; Accordingly, each of Seller and each Stockholder agrees that the Territory, time limitation and scope of restrictions set
          forth in this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6.02</u></font> are reasonable and necessary to protect the legitimate business interests of Buyer and to protect the benefit of Buyer&#8217;s bargain and the
          goodwill of the Business.&#160; Each of Seller and each Stockholder agrees that any reduction to the Territory, time limitation or scope of restrictions set forth herein would seriously undermine the efficacy of this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6.02</u></font> and the protections that it is intended to provide.&#160; Each of Seller and each Stockholder acknowledges and agrees that the covenants contained in this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6.02</u></font> are essential elements of this Agreement and that but for these covenants (and each of Seller&#8217;s and each Stockholder&#8217;s agreement that such covenants will be governed and enforced in
          accordance with the provisions of <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6.05</u></font>), Buyer would not have agreed to enter into this Agreement and consummate the Contemplated Transactions.&#160; Each of Seller
          and each Stockholder further expressly agrees and acknowledges that: (i) the nonsolicitation and non-competition covenants contained in this Agreement (A) are reasonable and necessary for the protection of Buyer with respect to the covenants&#8217;
          respective stated purposes, time, scope and geographic area, and are supported by adequate consideration, (B) are necessary for the protection of Buyer&#8217;s legitimate business interests, including the Trade Secrets, goodwill and relationships with
          customers and suppliers purchased by Buyer pursuant to this Agreement and (C) are not unduly restrictive of any rights of any of Seller or any Stockholder, (ii) each of Seller and each Stockholder has sufficient employment or business
          alternatives and sufficient assets, taking into account the Purchase Price and other consideration received and to be received, directly or indirectly, by such parties, such that such parties do not have to compete with Buyer or the Business or
          impermissibly disclose or use the Business&#8217; confidential information in order to earn a living and (iii) in entering into and negotiating this Agreement and the terms hereof, there has been no disparity in bargaining power between the parties,
          and Seller and the Stockholders have been represented by counsel and fully understand the terms hereof.&#160; The existence of any claim or cause of action against Buyer or its Affiliates by Seller, any Stockholder or any of his or its Affiliates,
          whether predicated on Buyer&#8217;s breach of this Agreement or otherwise, shall not constitute a defense to the enforcement by Buyer of the covenants contained in this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6.02</u></font>.</font></div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> <br>
        </font></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">13</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Injunction</u></font>.&#160; Seller and the Stockholders agree that a violation of the terms, provisions, obligations, duties and conditions described in this Agreement will cause irreparable damage to Buyer for which money damages or
          other legal remedies would not be an adequate remedy.&#160; Accordingly, Seller and the Stockholders acknowledge and agree that, in the event of any breach or threatened breach by Seller or any Stockholder of any of his or its covenants or obligations
          set forth in this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6.02</u></font>, Buyer shall be entitled to seek an injunction or injunctions, without the posting of any bond, to prevent or restrain breaches or
          threatened breaches of this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6.02</u></font>, and to specifically enforce the terms and provisions of this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section


              6.02</u></font> to prevent breaches or threatened breaches of, or to enforce compliance with, the covenants and obligations of this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6.02</u></font>.&#160; Seller and the
          Stockholders further agree that (x) by seeking the remedies provided for in this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6.02(c)</u></font>, Buyer shall not in any respect waive its right to seek any other form
          of relief that may be available under this Agreement (including monetary damages) or applicable Law and (y) nothing set forth in this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6.02(c)</u></font> shall require
          Buyer to institute any Action for (or limit Buyer&#8217;s right to institute any Action for) specific performance under this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6.02(c)</u></font> prior or as a condition to
          exercising any other rights under this Agreement or otherwise, nor shall the commencement of any Action pursuant to this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6.02(c)</u></font> or anything set forth in this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6.02(c)</u></font> restrict or limit Buyer&#8217;s right to pursue any other remedies under this Agreement or otherwise that may be available to Buyer thereafter.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Severability</u></font>.&#160; If any covenant or restriction contained in this <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 6.02</u></font>, or any part thereof, is hereafter construed or found to be
          invalid or unenforceable in part or in whole, this shall not affect the remainder of the covenants or restrictions, which shall be given full effect, without regard to the invalid or unenforceable portions, and any court having jurisdiction shall
          enforce such invalid or unenforceable covenant or restriction to the maximum extent possible under applicable Law, including the maximum permissible time, scope and geographic area for such covenant or restriction.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">6.03 &#160; &#160; </font><u>Investigation



            and Reliance</u></font>.&#160; Each of Seller and each Stockholder, on one hand, and Buyer, on the other, is a sophisticated seller or purchaser, as the case may be, and has made its own independent investigation, review and analysis regarding the
        other parties, including any publicly available information regarding such parties (if any), and the Contemplated Transactions, which investigation, review and analysis were conducted by such party together with its advisors, including legal
        counsel, that it has engaged for such purpose. No party or any of its Affiliates or Representatives has made any representation or warranty, express or implied, as to the accuracy or completeness of any information concerning such party made
        available in connection with any investigation of such party, except as expressly set forth in this Agreement. No party has relied and no party is relying on any statement, representation or warranty, oral or written, express or implied, made by
        any other party, or any of such other party&#8217;s Affiliates or Representatives, except as expressly set forth in <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Article III</u></font>, <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Article IV</u></font> or any certificates executed and delivered in connection with the consummation of the Contemplated Transactions. No party or any of its Affiliates or Representatives shall have or be subject to any
        liability to any other party or any other Person resulting from the distribution to any other party, or such other party&#8217;s use of, any information, documents or materials made available to such party in connection with the negotiation, execution or
        delivery of this Agreement. No party or any of its Affiliates or Representatives is making, directly or indirectly, any representation or warranty with respect to any estimates, projections or forecasts involving such party or any other Person.
        Each party acknowledges that there are inherent uncertainties in attempting to make such estimates, projections and forecasts and that it takes full responsibility for making its own evaluation of the adequacy and accuracy of any such estimates,
        projections or forecasts (including the reasonableness of the assumptions underlying any such estimates, projections and forecasts).</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">14</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">6.04 &#160; &#160;&#160; </font><u>Public



            Announcements</u></font>.&#160; From and after the Closing, none of Seller, any Affiliate of Seller or any Stockholder, on the one hand, nor Buyer or any Affiliate of Buyer, on the other hand, shall, directly or indirectly, issue any press release
        or public announcement concerning this Agreement or the Contemplated Transactions hereby without obtaining the prior written approval of the other parties hereto, which approval may be withheld by any party hereto in its sole discretion; <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>provided</u></font> that, without the consent of Seller or any Stockholder, Buyer may make any public disclosure that is required under applicable Law, including the Securities Act and
        the Exchange Act, or under the rules of any securities exchange on which Buyer&#8217;s securities are then listed, quoted or admitted for trading.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">6.05 &#160; &#160;&#160;&#160; </font><u>Governing



            Law, Jurisdiction; Waiver of Jury Trial</u></font>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">This Agreement, its construction and the
          determination of any rights, duties or remedies of the parties arising out of or relating to this Agreement shall be governed by and construed in accordance with the domestic laws of the State of Delaware without giving effect to any choice or
          conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Delaware.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Jurisdiction; Service of Process</u></font>.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Jurisdiction</u></font>.&#160; Each party, by its execution hereof, (a) hereby irrevocably submits to the non-exclusive jurisdiction of the Delaware Court of Chancery or the United States District Courts located in Wilmington,
          Delaware or any other court in the United States having jurisdiction as a result of being in the situs where the alleged Action arose, for the purpose of any Action between or among the parties (or any of them) arising in whole or in part under
          or in connection with this Agreement, (b) hereby waives and agrees not to assert, by way of motion, as a defense or otherwise, in any such Action, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its
          property is exempt or immune from attachment or execution, that any such Action brought in one of the above-named courts should be dismissed on grounds of forum non conveniens, should be transferred or removed to any court other than one of the
          above-named courts, or that this Agreement or the subject matter hereof may not be enforced in or by such court.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Service of Process</u></font>.&#160; Each party hereby (a) consents to service of process in any Action between the parties arising in whole or in part under or in connection with this Agreement in any manner permitted by the Laws of
          the State of Delaware, (b) agrees that service of process made in accordance with clause (a) will constitute good and valid service of process in any such Action and (c) waives and agrees not to assert (by way of motion, as a defense, or
          otherwise) in any such Action any claim that service of process made in accordance with clause (a) does not constitute good and valid service of process.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Waiver of Jury Trial</u></font>.&#160; THE PARTIES HEREBY WAIVE, AND COVENANT THAT THEY WILL NOT ASSERT (WHETHER AS PLAINTIFF, DEFENDANT OR OTHERWISE), ANY RIGHT TO TRIAL BY JURY IN ANY ACTION ARISING IN WHOLE OR IN PART UNDER OR IN
          CONNECTION WITH THIS AGREEMENT OR ANY OF THE CONTEMPLATED TRANSACTIONS, WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER SOUNDING IN CONTRACT, TORT OR OTHERWISE.&#160; THE PARTIES AGREE THAT ANY OF THEM MAY FILE A COPY OF THIS PARAGRAPH WITH ANY
          COURT AS WRITTEN EVIDENCE OF THE KNOWING, VOLUNTARY AND BARGAINED-FOR AGREEMENT AMONG THE PARTIES IRREVOCABLY TO WAIVE THEIR RESPECTIVE RIGHTS TO TRIAL BY JURY IN ANY ACTION WHATSOEVER BETWEEN OR AMONG THEM RELATING TO THIS AGREEMENT OR ANY OF
          THE CONTEMPLATED TRANSACTIONS, WHICH ACTION WILL INSTEAD BE TRIED IN A COURT OF COMPETENT JURISDICTION BY A JUDGE SITTING WITHOUT A JURY.</font></div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">15</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">6.06 &#160; &#160; </font><u>Entire




            Agreement</u></font>.&#160; This Agreement and the Ancillary Agreements constitute the entire agreement among the parties pertaining to the subject matter hereof and supersede all prior and contemporaneous agreements, understandings, negotiations
        and discussions, whether oral or written, of the parties, and there are no representations, warranties, covenants or other agreements between the parties in connection with the subject matter hereof except as set forth specifically herein.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">6.07 &#160; &#160; &#160;</font> <u>Further



            Assurances</u></font>.&#160; Following the Closing, each of the parties shall, and shall cause their respective Affiliates to, execute and deliver such additional documents, instruments, conveyances and assurances and take such further actions as
        may be reasonably required to carry out the provisions hereof and give effect to the transactions contemplated by this Agreement and the other Ancillary Agreements.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">6.08 &#160; &#160; &#160;</font> <u>Severability</u></font>.&#160;



        If any provision of this Agreement is held to be unenforceable for any reason, it shall be adjusted rather than voided, if possible, in order to achieve the intent of the parties to this Agreement to the fullest extent possible.&#160; In any event, all
        other provisions of this Agreement shall be deemed valid and enforceable to the fullest extent possible.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">6.09 &#160; &#160; &#160;</font> <u>Amendment;



            Waiver</u></font>.&#160; No amendment or waiver of any provision of this Agreement will be valid and binding unless it is in writing and signed, in the case of an amendment, by Buyer, Seller and the Stockholders, or in the case of a waiver, by the
        party or parties against whom the waiver is to be effective.&#160; No waiver by any party of any breach or violation or, default under or inaccuracy in any representation, warranty or covenant hereunder, whether intentional or not, will be deemed to
        extend to any prior or subsequent breach, violation, default of, or inaccuracy in, any such representation, warranty or covenant hereunder or affect in any way any rights arising by virtue of any prior or subsequent such occurrence.&#160; No delay or
        omission on the part of any party in exercising any right, power or remedy under this Agreement will operate as a waiver thereof.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">6.10 &#160; &#160; &#160;</font> <u>Successors



            and Assigns; No Third-Party Beneficiaries</u></font>.&#160; All of the terms and provisions of this Agreement by or for the benefit of the parties shall be binding upon and inure to the benefit of their respective successors, permitted assigns,
        heirs and personal representatives.&#160; The rights and obligations provided by this Agreement shall not be assignable by any party; provided, that Buyer may assign its rights and obligations under this Agreement (without discharge of its obligations
        hereunder) to a Subsidiary or Affiliate (in each case, provided that Buyer shall remain liable for any and all payment obligations under <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 1.04</u></font>) or a successor to
        its business (in which case such successor has assumed all of Buyer&#8217;s liabilities hereunder).&#160; Except as expressly provided herein, nothing herein is intended to confer upon any Person, other than the parties and their respective successors and
        permitted assigns, any legal or equitable rights or remedies under or by reason of this Agreement.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">6.11 &#160; &#160; &#160;&#160;</font></font> <u>Survival</u></font>.&#160; The covenants and agreements and, subject to <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 5.02</u></font>,
        the representations and warranties set forth in this Agreement shall survive and remain in effect after the Closing.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">16</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">6.12&#160; &#160; &#160; &#160;</font></font> <u>Interpretation; Rules of Construction</u></font>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">The parties have participated jointly in the
          negotiation and drafting of this Agreement.&#160; In the event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the parties and no presumption or burden of proof shall arise
          favoring or disfavoring any party by virtue of the authorship of any of the provisions of this Agreement.&#160; Any reference to any federal, state, local, or foreign statute or law shall be deemed also to refer to all rules and regulations
          promulgated thereunder, in each case as amended or otherwise modified from time to time, unless the context requires otherwise.&#160; The term &#8220;including&#8221; shall mean &#8220;including without limitation&#8221;.&#160; The word &#8220;or&#8221; shall not be exclusive.&#160; The parties
          intend that each representation, warranty, and covenant contained herein shall have independent significance.&#160; If any party has breached any representation, warranty or covenant contained herein in any respect, the fact that there exists another
          representation, warranty or covenant relating to the same subject matter (regardless of the relative levels of specificity) which the party has not breached shall not detract from or mitigate the fact that the party is in breach of the first
          representation, warranty or covenant.&#160; Each reference to a Section, Exhibit or Schedule means a Section of, or Schedule or Exhibit to this Agreement, unless another agreement is specified.&#160; Words in the singular or plural form include the plural
          and singular form, respectively.&#160; References to a particular Person include such Person&#8217;s successors and assigns to the extent not prohibited by this Agreement.&#160; All pronouns and any variations thereof refer to the masculine, feminine or neuter
          singular or plural as the identity of the Person or Persons may require.&#160; The terms &#8220;hereof&#8221;, &#8220;herein&#8221;, &#8220;hereunder&#8221;, &#8220;hereto&#8221; and &#8220;herewith&#8221; and words of similar import shall, unless otherwise stated, be construed to refer to this Agreement and
          not to any particular provision of this Agreement.&#160; All references herein to &#8220;$&#8221; are to United States dollars.&#160; Any accounting term used in this Agreement shall have, unless otherwise specifically provided herein, the meaning customarily given
          such term in accordance with GAAP and all financial computations hereunder will be computed, unless otherwise specifically provided herein, in accordance with GAAP consistently applied.&#160; All references herein to a &#8220;party&#8221; or &#8220;parties&#8221; are to a
          party or parties to this Agreement unless otherwise specified.&#160; The phrases &#8220;date of this Agreement,&#8221; &#8220;date hereof&#8221; and terms of similar impart, unless the context otherwise requires, shall be deemed to refer to the date set forth in the preamble
          of this Agreement.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Titles and headings to sections and subsections
          herein are inserted for convenience of reference only and are not intended to be a part of or to affect the meaning or interpretation of this Agreement.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">6.13 &#160; &#160; &#160;</font></font></font> Notices.&#160; All notices, requests, demands, claims and other communications required or permitted to be delivered, given or otherwise provided under this
        Agreement must be in writing and must be delivered, given or otherwise provided:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">by hand (in which case, it will be effective upon
          delivery);</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">if sent by e-mail (in which case, it will be
          effective when sent, provided that such sent e-mail is kept on file (whether electronically or otherwise) by the sending party and the sending party does not receive an automatically generated message from the recipient&#8217;s e-mail server that such
          e-mail could not be delivered to such recipient); or</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">by overnight delivery by a nationally recognized
          courier service (in which case, it will be effective on the Business Day after being deposited with such courier service);</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">in each case, to the address (or email address) listed below:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">If to Buyer to</font></div>
      <div>&#160;</div>
      <div style="text-align: left; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">Eterna Therapeutics Inc.</div>
      <div style="text-align: left; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">1035 Cambridge Street</div>
      <div style="text-align: left; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">Suite 18A</div>
      <div style="text-align: left; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">Cambridge, MA 02141</div>
      <div style="text-align: left; margin-left: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Attn:</font>&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Sandra Gurrola, Vice President, Finance</font></div>
      <div style="text-align: left; margin-left: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Email:</font>&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">sandra.gurrola@eternatx.com</font></div>
      <div>&#160;</div>
      <div style="text-align: left; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">with a copy (which shall not constitute notice) to</div>
      <div>&#160;</div>
      <div style="text-align: left; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">Greenberg Traurig, P.A.</div>
      <div style="text-align: left; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">333 S.E. 2<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">nd</sup> Avenue</div>
      <div style="text-align: left; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">Suite 4400</div>
      <div style="text-align: left; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">Miami, FL 33131</div>
      <div style="text-align: left; margin-left: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Attn:</font>&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Drew M. Altman, Esq.</font></div>
      <div style="text-align: left; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">Telephone:&#160; (305) 579-0589</div>
      <div style="text-align: left; margin-left: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Email:</font>&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">altmand@gtlaw.com</font></div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">17</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">If to Seller:</font></div>
      <div>&#160;</div>
      <div style="text-align: left; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">Exacis Biotherapeutics Inc.</div>
      <div style="text-align: left; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">1035 Cambridge Street</div>
      <div style="text-align: left; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">Suite 17B</div>
      <div style="text-align: left; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">Cambridge, MA 02141</div>
      <div style="text-align: left; margin-left: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Attn:</font>&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Gregory Fiore, M.D.</font></div>
      <div style="text-align: left; margin-left: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Email:</font>&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">greg.fiore@exacis.com</font></div>
      <div>&#160;</div>
      <div style="text-align: left; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">with a copy (which shall not constitute notice) to</div>
      <div>&#160;</div>
      <div style="text-align: left; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">Ice Miller LLP</div>
      <div style="text-align: left; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">250 West Street</div>
      <div style="text-align: left; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">Suite 700</div>
      <div style="text-align: left; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">Columbus, OH 43215</div>
      <div style="text-align: left; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">Attn:&#160; Edward J. Braum</div>
      <div style="text-align: left; margin-left: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Email:</font>&#160; &#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">edward.braum@icemiller.com</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">or to such other address or e-mail address and/or to the attention of such other Person as the recipient party has specified by written notice given to each other
        party five (5) days prior to the effectiveness of such change.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">6.14 &#160; &#160; &#160;</font></font> <u>Fees and Expenses</u></font>.&#160; Each party to this Agreement shall be responsible for, and will pay, all of its own fees and expenses, including those for
        its own legal counsel and accountants, incurred in the negotiation, preparation, and consummation of this Agreement and the Ancillary Agreements.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">6.15 &#160; &#160; &#160;</font></font> <u>Schedules; Listed Documents</u></font>.&#160; Neither the listing nor description of any item, matter or document in any Schedule hereto nor the furnishing or
        availability for review of any document will be construed to modify, qualify or disclose an exception to any representation or warranty of any party made herein or in connection herewith, except to the extent that such representation or warranty
        specifically refers to such Schedule and such modification, qualification or exception is clearly described in such Schedule; provided, that the information and disclosures contained in any section of Seller&#8217;s Disclosure Schedule shall be deemed to
        be disclosed and incorporated by reference in any other section of Seller&#8217;s Disclosure Schedule as though fully set forth in such section for which applicability of such information and disclosure is reasonably apparent on its face.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">6.16 &#160; &#160; &#160;</font></font> <u>Counterparts</u></font>.&#160; This Agreement may be executed in any number of counterparts, each of which will be deemed an original, but all of which together
        will constitute but one and the same instrument.&#160; This Agreement will become effective when duly executed by each party hereto.&#160; Facsimile, other electronically scanned and transmitted signatures, including by email attachment, and electronic
        signatures, including by DocuSign, shall be deemed originals and shall constitute valid execution and acceptance of this Agreement by the signing/transmitting party.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">18</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE VII</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">DEFINITIONS</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">7.01 &#160; &#160;&#160; </font><u>Definitions</u></font>.&#160;



        As used herein, the following terms will have the following meanings:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Action</u></font>&#8221; means any claim, action, cause of action or suit (whether in
        contract, tort or otherwise), litigation (whether at law or in equity, whether civil or criminal), controversy, assessment, arbitration, investigation, hearing, charge, complaint, demand, notice or proceeding to, from, by or before any Governmental
        Authority.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Affiliate</u></font>&#8221; means with respect to any specified Person, (a) each Person
        directly or indirectly controlling, controlled by or under direct or indirect common control with such specified Person at such time, (b) each Person who is at such time an officer, limited liability company manager or director of, or direct or
        indirect beneficial holder of at least 10% of any class of the capital stock of, such specified Person, (c) each Person that is managed by a common group of executive officers, limited liability company managers and/or directors as such specified
        Person, and (d) each Person of which such specified Person or an Affiliate (as defined in clauses (a) through (c)) thereof will, directly or indirectly, beneficially own at least 10% of any class of Equity Interests at such time.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Ancillary Agreements</u></font>&#8221; means each other agreement, document, instrument
        or certificate contemplated by this Agreement or to be executed by Seller or any Stockholder, as applicable, in connection with the consummation of the Contemplated Transactions.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Business Day</u></font>&#8221; means any weekday other than a weekday on which banks in
        Cambridge, Massachusetts are authorized or required to be closed.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Buyer Common Stock</u></font>&#8221; means the common stock, par value $0.005 per
        share, of Buyer.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Change of Control</u></font>&#8221; means, with respect to Buyer, the consummation of a
        transaction (or a series of related transactions) that results in (i) the liquidation or dissolution of Buyer, (ii) the sale of all or substantially all assets of Buyer or (iii) any &#8220;person&#8221; (as such term is used in Section 13(d)(3) of the Exchange
        Act), other than a Permitted Holder, becoming the &#8220;beneficial owner&#8221; (as defined in Rules 13d-3 and 13d-5 under the Exchange Act), directly or indirectly, of more than 50% of the total voting power of the Company issued and outstanding voting
        equity securities; provided that the consummation of any such transaction resulting in such person owning more than 50% of the total voting power of the issued and outstanding voting equity securities shall not be considered a Change of Control if
        (a) the Company becomes a direct or indirect wholly owned subsidiary of a holding company and (b) immediately following such transaction, the direct or indirect holders of the voting securities of the holding company are substantially the same as
        the holders of the issued and outstanding Buyer Common Stock immediately prior to such transaction.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Contemplated Transactions</u></font>&#8221; means the purchase and sale of the
        Purchased Assets and the assumption by Buyer of the Assumed Liabilities and the other transactions contemplated by this Agreement and the Ancillary Agreements.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Contract</u></font>&#8221; means all agreements, commitments, purchase or sales orders,
        personal property leases, real property leases, distribution agreements, vendor agreements, agreements in respect of Indebtedness and other instruments of any kind, whether written or oral.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">19</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Equity Interest</u></font>&#8221; of any Person means any (i) capital stock, membership
        or partnership interest, unit or other ownership interest of or in such Person, (ii) securities directly or indirectly convertible into or exchangeable for any for the foregoing, (iii) options, warrants or other rights directly or indirectly to
        purchase or subscribe for any of the foregoing or securities convertible into or exchangeable for any of the foregoing or (iv) Contracts, commitments and agreements relating to the issuance of any of the foregoing or giving any Person the right to
        participate in or receive any payment based on the profits or performance of such Person (including any equity appreciation, phantom equity or similar plan or right).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Exacis Convertible Notes</u></font>&#8221; means that certain series of unsecured
        convertible promissory bridge notes identified on <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Exhibit C</u></font> in the aggregate principal amount of $3,000,000.00.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Exchange Act</u></font>&#8221; means the Securities Exchange Act of 1934, as amended.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>GAAP</u></font>&#8221; means United States generally accepted accounting principles
        consistently applied.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Governmental Authority</u></font>&#8221; means any foreign, domestic, federal,
        territorial, state or local governmental authority, quasi-governmental authority, court, commission, board, bureau, agency or instrumentality, or any regulatory, administrative or other department, agency, or any political or other subdivision,
        department or branch of any of the foregoing.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Indebtedness</u></font>&#8221; means, with respect to any Person, all obligations
        (including all obligations in respect of principal, accrued interest, penalties, fees and premiums) of such Person, whether direct or indirect, (a) for borrowed money (including overdraft facilities), (b) for Liabilities secured by any Lien
        existing on property owned or acquired and subject thereto, (c) evidenced by notes, bonds, debentures or similar Contracts, (d) for the deferred purchase price of property, goods or services, including in connection with the acquisition of any
        business or non-competition agreement (other than trade payables or accruals incurred in the Ordinary Course of Business), (e) under capital leases (in accordance with GAAP), (f) in respect of letters of credit and bankers&#8217; acceptances, (g) for
        Contracts relating to interest rate protection, swap agreements, factoring, hedging and collar agreements, (h) in the nature of premiums (prepayment or otherwise) or penalties in connection with the obligations described in clauses (a) through (g)
        above, and (h) in the nature of guarantees of the obligations described in clauses (a) through (g) above of any other Person.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Intellectual Property</u></font>&#8221; means any and all of the following in any
        jurisdiction throughout the world, presently or hereafter existing, whether arising by operation of law, contract, license or otherwise: (i) patents, industrial design registrations, patent applications, patent and industrial design disclosures and
        inventions (whether or not patentable or reduced to practice), and all improvements thereto, as well as any reissues, continuations, continuations in part, divisionals, revisions, extensions or reexaminations thereof; (ii) trademarks, service
        marks, designs, trade dress, trade names, slogans, logos, internet domain names, social media handles, business names, corporate names, and all other indicia of origin, and registrations and applications for registration thereof, together with all
        of the goodwill associated with any of the foregoing and all common law rights with respect thereto; (iii) all works of authorship (whether or not copyrightable) and copyrights, compilations, database rights and moral rights, rights of attribution
        or integrity, and registrations and applications for registration thereof; (iv) Trade Secrets; (v) rights of publicity, privacy or other name and likeness rights; (vi) all other intellectual property and proprietary rights; (vii) all Actions and
        rights to sue at law or in equity for any past, present or future infringement or other impairment of any of the foregoing, including the right to receive all proceeds and damages therefrom; and (viii) all copies and tangible embodiments or
        descriptions of any of the foregoing (in whatever form or medium).</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Issued and Outstanding Shares</u></font>&#8221; means, with respect to Buyer Common
        Stock, all such shares actually issued and outstanding on the applicable date of determination, which, for the elimination of doubt, excludes all shares of Buyer Common Stock issuable or potentially issuable upon the exercise, conversion or vesting
        of all outstanding derivative securities, including options, warrants, restricted stock units, preferred stock and convertible debt, as well as any shares of Buyer Common Stock issuable or potentially issuable under this Agreement or any other
        Contract.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">20</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Law</u></font>&#8221; means any United States federal, national, foreign,
        supranational, state, provincial, local or similar statute, law, standard, resolution, promulgation, ordinance, regulation, rule, code, order, requirement or rule of law (including common law), or any similar provision having the force or effect of
        law.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Liabilities</u></font>&#8221; means, with respect to any Person, any liability or
        obligation of such Person, of any kind, character or description, whether known or unknown, whether asserted or unasserted, whether executory, determined, determinable or otherwise, whether absolute or contingent, whether accrued or unaccrued,
        whether liquidated or unliquidated, whether disputed or undisputed, whether disclosed or undisclosed, whether incurred or consequential, whether secured or unsecured, joint or several, vested or unvested, whether due or to become due, whether
        choate or inchoate and whether or not required under GAAP to be accrued on the financial statements of such Person and regardless of whether such debt, duty or Liability is immediately due and payable, and including all costs and expenses related
        thereto.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Lien</u></font>&#8221; means any charge, claim, community or other marital property
        interest, condition, equitable interest, lien, license, option, pledge, security interest, mortgage, right of way, easement, encroachment, servitude, right of first offer or first refusal, buy/sell agreement and any other restriction or covenant
        with respect to, or condition governing the use, construction, voting (in the case of any security or Equity Interest), transfer, receipt of income or exercise of any other attribute of ownership.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Permitted Holder</u></font>&#8221; means any of those persons identified on <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Exhibit B</u></font>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Person</u></font>&#8221; means any natural person, corporation, association,
        partnership, organization, business, limited liability company, firm, trust, joint venture, unincorporated organization or any other entity or organization, including a Governmental Authority.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Pro Rata Share</u></font>&#8221; means, with respect to each Stockholder, without
        duplication, such Stockholder&#8217;s pro rata share of the Purchase Price, as set forth on <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Exhibit A</u></font>.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Representative</u></font>&#8221; means, with respect to any Person, any officer,
        director, principal, attorney, agent, employee or other representative of such Person.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Retained Intellectual Property</u></font>&#8221; means the commercial off-the-shelf
        software licensed to or otherwise used by Seller.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>SEC</u></font>&#8221; means the U.S. Securities and Exchange Commission.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Securities Act</u></font>&#8221; means the Securities Act of 1933, as amended.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Seller&#8217;s Disclosure Schedule</u></font>&#8221; means the disclosure schedules attached
        hereto and delivered by Seller and the Stockholders to Buyer in connection with this Agreement.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Seller&#8217;s Knowledge</u></font>&#8221; means the actual knowledge of the Stockholders, in
        each case including such knowledge that would be acquired by such persons through their reasonable inquiry.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Subsidiary</u></font>&#8221; means, with respect to any specified Person, any other
        Person of which such specified Person will, at the time, directly or indirectly through one or more Subsidiaries, (a) own at least 50% of the outstanding capital stock (or other shares of beneficial interest) entitled to vote generally, (b) hold at
        least 50% of the partnership, limited liability company, joint venture or similar interests or (c) be a general partner, managing member or joint venturer.</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">21</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Tax</u></font>&#8221; or &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Taxes</u></font>&#8221; means any</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">federal, state, local or foreign income, gross
          receipts, franchise, estimated, alternative minimum, add-on minimum, sales, use, transfer, registration, value added, excise, natural resources, severance, stamp, occupation, premium, windfall profit, environmental, customs, duties, real
          property, personal property, capital stock, social security, unemployment, disability, payroll, license, employee or other withholding, or other tax, of any kind whatsoever, including any interest, penalties or additions to tax or additional
          amounts in respect of the foregoing;</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Liability of Seller or any Stockholder for the
          payment of any amounts of the type described in clause (i) arising as a result of being (or ceasing to be) a Stockholder of any affiliated group (or being included (or required to be included) in any Tax Return relating thereto) for any period
          ending on or before the Closing Date; and</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 108pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';">Liability of Seller or any Stockholder for the
          payment of any amounts of the type described in clause (i) as a result of any express or implied obligation (legal, contractual or otherwise) to indemnify or otherwise assume or succeed to the liability of any other Person related to any period
          ending on or before the Closing Date.</font></div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Tax Return</u></font>&#8221; means all returns, declarations, reports, claims for
        refund, information returns or other documents (including any related or supporting schedules or statements of information) filed or required to be filed in connection with the determination, assessment or collection of Taxes of any party or the
        administration of any Laws relating to any Taxes.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Total Market Capitalization</u></font>&#8221; means the amount equal to (i) the closing
        price of the Buyer Common Stock as reported on the Trading Market on the applicable date of calculation, <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>multiplied by</u></font> (ii) the number of Issued and Outstanding Shares of
        Buyer Common Stock on such date.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Trade Secrets</u></font>&#8221; means trade secrets and other confidential or
        proprietary information (including ideas, formulas, patterns, compilations, compositions, know how, processes, techniques, technologies, methods, algorithms, research and development information, specifications, data, pricing and cost information
        and customer and supplier lists and information) and any other information that derives independent economic value, actual or potential, from not being generally known to, and not being readily ascertainable by proper means by, other persons who
        can obtain economic value from its disclosure or use, and is the subject of efforts that are reasonable under the circumstances to maintain its secrecy.</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Trading Market</u></font>&#8221; means any of the following markets or exchanges on
        which the Buyer Common Stock is listed or quoted for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market or the New York Stock Exchange (or any successors to any
        of the foregoing); <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>provided</u></font>, that if the Buyer Common Stock is not listed or quoted on any of the foregoing markets (or any successors thereto), then Trading Market shall
        mean the OTCQB, OTCQX or The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting prices).</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">22</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">7.02&#160; &#160; &#160;&#160;&#160; </font></font><u>Other Defined Terms</u></font>.&#160; The following capitalized terms have the meanings in the sections indicated below.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" align="center" id="z2108d16d571745979d3c10c14c754920" style="border-collapse: collapse; width: 70%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;">

          <tr>
            <td style="width: 55%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Defined Term</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Section Reference</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Agreement</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Preamble</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Assumed Liabilities</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">1.02</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Business</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">6.02(a)(i)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Buyer</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Preamble</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Buyer Indemnified Parties</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">5.01</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Closing</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">2.01</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Closing Date</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">2.01</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Closing Date Shares</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">1.04(a)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Competitive Business</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">6.02(a)(i)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Consideration Shares</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">1.04(c)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Contingent Shares</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">1.04(c)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Deductible</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">5.03</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Exacis Granted Rights</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">6.01</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Excluded Liabilities</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">1.03</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Factor</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Preamble</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Factor-Eterna License Agreement</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">6.01</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">First Contingent Installment Shares</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">1.04(b)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Five-Year Period</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">1.04(d)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Indemnified Party</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">5.06(a)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Indemnifying Party</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">5.06(a)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Indemnity Cap</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">5.03</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">License Consideration</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">1.04(d)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Licensor</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Recitals</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Loss</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">5.01</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Losses</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">5.01</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Measurement Period</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">1.04(b)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Purchase Price</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">1.04</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Purchased Assets</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">1.01</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Purchased License</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Recitals</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Restriction</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">3.07(a)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Second Continent Installment Shares</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">1.04(c)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Seller</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Preamble</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Seller Allocation</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">1.04</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Seller Indemnified Parties</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">5.04</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Stockholder</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Preamble</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Stockholders</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Preamble</div>
            </td>
          </tr>
          <tr>
            <td style="width: 55%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Territory</div>
            </td>
            <td style="width: 15%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">6.02(a)</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';">7.03&#160;&#160;&#160;&#160; </font></font><u>Incorporation of Certain Terms From Purchased License</u></font>.&#160; Capitalized terms used in this Agreement and not defined herein have the respective
        meanings ascribed thereto in the Purchased License.</div>
      <div>&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">[Signature Page Follows]</div>
      <div>&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">23</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">IN WITNESS WHEREOF, the undersigned have executed and delivered this Agreement as of the date and year first above written.</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" id="z969f21165a1741f5915c68265ea04f4c" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="vertical-align: top; width: 50%;">&#160;</td>
            <td style="vertical-align: top;" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">BUYER:</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; width: 50%;" rowspan="1">&#160;</td>
            <td style="vertical-align: top;" rowspan="1" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top; width: 50%;">&#160;</td>
            <td style="vertical-align: top;" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Eterna Therapeutics Inc.</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; width: 50%;" rowspan="1">&#160;</td>
            <td style="vertical-align: top;" rowspan="1" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top; padding-bottom: 2px; width: 50%;" rowspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;" rowspan="1"><font style="font-size: 10pt; font-family: 'Times New Roman';">By:</font></td>
            <td style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">
              <div style="margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">/s/ Matthew Angel</font></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; width: 50%;" rowspan="1">&#160;</td>
            <td style="vertical-align: top;" rowspan="1" colspan="2">Name: Matthew Angel</td>
          </tr>
          <tr>
            <td style="vertical-align: top; width: 50%;" rowspan="1">&#160;</td>
            <td style="vertical-align: top;" rowspan="1" colspan="2">Its: President and Chief Executive Officer</td>
          </tr>
          <tr>
            <td style="vertical-align: top; width: 50%;">&#160;</td>
            <td style="vertical-align: top;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top; width: 50%;">&#160;</td>
            <td style="vertical-align: top;" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">SELLER:</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; width: 50%;">&#160;</td>
            <td style="vertical-align: top;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top; width: 50%;">&#160;</td>
            <td style="vertical-align: top;" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Exacis Biotherapeutics Inc.</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; width: 50%;" rowspan="1">&#160;</td>
            <td style="vertical-align: top;" rowspan="1" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top; padding-bottom: 2px; width: 50%;" rowspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;" rowspan="1">
              <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">By:<br>
                </font></div>
            </td>
            <td style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">
              <div style="margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">/s/ Gregory Fiore</font></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; width: 50%;" rowspan="1">&#160;</td>
            <td style="vertical-align: top;" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Name: Gregory Fiore, MD</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; width: 50%;" rowspan="1">&#160;</td>
            <td style="vertical-align: top;" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Its: Chief Executive Officer</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; width: 50%;">&#160;</td>
            <td style="vertical-align: top;" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top; width: 50%;">&#160;</td>
            <td style="vertical-align: top;" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">STOCKHOLDERS:</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; width: 50%;" rowspan="1">&#160;</td>
            <td style="vertical-align: top;" rowspan="1" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top; width: 50%;" rowspan="1">&#160;</td>
            <td style="vertical-align: top;" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Factor Bioscience LLC</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; width: 50%;" rowspan="1">&#160;</td>
            <td style="vertical-align: top;" rowspan="1" colspan="2">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top; padding-bottom: 2px; width: 50%;" rowspan="1">&#160;</td>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;" rowspan="1">
              <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';">By:<br>
                </font></div>
            </td>
            <td style="width: 47%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">
              <div style="margin-left: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">/s/ Matthew Angel</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
                </font></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; width: 50%;" rowspan="1">&#160;</td>
            <td style="vertical-align: top;" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Name: Matthew Angel, PhD</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; width: 50%;" rowspan="1">&#160;</td>
            <td style="vertical-align: top;" rowspan="1" colspan="2">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Its: Chief Executive Officer</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; width: 50%;">&#160;</td>
            <td style="vertical-align: top;" colspan="2">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="vertical-align: top; padding-bottom: 2px; width: 50%;">&#160;</td>
            <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">/s/ Gregory Fiore</font> </div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; width: 50%;" rowspan="1">&#160;</td>
            <td style="vertical-align: top; width: 50%;" rowspan="1">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Dr. Gregory Fiore</div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; width: 50%;">&#160;</td>
            <td style="vertical-align: top; width: 50%;">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top; width: 50%;">&#160;</td>
            <td style="vertical-align: top; width: 50%;">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="vertical-align: top; padding-bottom: 2px; width: 50.44%;">&#160;</td>
            <td style="width: 50%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">/s/ James Pan</font></div>
            </td>
          </tr>
          <tr>
            <td style="vertical-align: top; width: 50.44%;" rowspan="1">&#160;</td>
            <td style="vertical-align: top; width: 50%;" rowspan="1">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">James Pan</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="vertical-align: top;" colspan="3">&#160;</td>
            <td style="vertical-align: top; width: 50%;">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top;" colspan="3">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Factor Bioscience Limited</div>
            </td>
            <td style="vertical-align: top; width: 50%;">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top;" rowspan="1" colspan="3">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">(solely for purposes of<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">&#160;</font>Section 6.01)</div>
            </td>
            <td style="vertical-align: top; width: 50%;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top;" rowspan="1" colspan="3">&#160;</td>
            <td style="vertical-align: top; width: 50%;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px;" rowspan="1"><font style="font-size: 10pt; font-family: 'Times New Roman';">By:</font></td>
            <td style="width: 38%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1">
              <div><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">/s/ Matthew Angel</font></div>
            </td>
            <td style="width: 9%; vertical-align: top; padding-bottom: 2px;" rowspan="1"><br>
            </td>
            <td style="vertical-align: top; padding-bottom: 2px; width: 50%;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top;" rowspan="1" colspan="3">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Name:&#160; Matthew Angel, PhD</div>
            </td>
            <td style="vertical-align: top; width: 50%;" rowspan="1">&#160;</td>
          </tr>
          <tr>
            <td style="vertical-align: top;" rowspan="1" colspan="3">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Its: Chief Executive Officer</div>
            </td>
            <td style="vertical-align: top; width: 50%;" rowspan="1">&#160;</td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="text-align: center;">
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[Signature Page to Asset Purchase Agreement]</div>
        <div><br>
        </div>
        <br>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>erna-20230426.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.3.2.5148 Broadridge-->
<xs:schema targetNamespace="http://eternatx.com/20230426" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:erna="http://eternatx.com/20230426" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="erna-20230426_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="erna-20230426_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://eternatx.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2022" schemaLocation="https://xbrl.sec.gov/currency/2022/currency-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2022" schemaLocation="https://xbrl.sec.gov/exch/2022/exch-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2022" schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2022" schemaLocation="https://xbrl.sec.gov/sic/2022/sic-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>erna-20230426_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.3.2.5148 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>erna-20230426_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.3.2.5148 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://eternatx.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="erna-20230426.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://eternatx.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140274391818656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Apr. 26, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 26,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-11460<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Eterna Therapeutics Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000748592<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">31-1103425<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1035 Cambridge Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 18A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cambridge<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">582-1199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.005 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ERNA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>brhc20052311_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="erna-20230426.xsd" xlink:type="simple"/>
    <context id="c20230426to20230426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000748592</identifier>
        </entity>
        <period>
            <startDate>2023-04-26</startDate>
            <endDate>2023-04-26</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20230426to20230426"
      id="Fact_21f381c9fb164dd18f6ce94bb19d81d1">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20230426to20230426"
      id="Fact_70012f83b60c42189eb543ab4d706db1">0000748592</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20230426to20230426"
      id="Fact_9f77ad0a939645e294dfb8a69d709812">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20230426to20230426"
      id="Fact_da84d6318532426ca195e2c080847c19">2023-04-26</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20230426to20230426"
      id="Fact_f89e0142257f4af681f9bdf07476506f">Eterna Therapeutics Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20230426to20230426"
      id="Fact_4b5e76b4e5a04b36ba80775ec0c10cb1">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20230426to20230426"
      id="Fact_4bedcc66fc364ee0b2ca3f2cb2518a2c">001-11460</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20230426to20230426"
      id="Fact_26a694fe55e04051b78a47732415bfe3">31-1103425</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20230426to20230426"
      id="Fact_a5cc6e001e0b43fd8df665ac087d1d77">1035 Cambridge Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="c20230426to20230426"
      id="Fact_9e589bee5d4d4026a2be724f38ecd6c2">Suite 18A</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="c20230426to20230426"
      id="Fact_8152fb48fa6d4ab2a432c3d17bc76b07">Cambridge</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20230426to20230426"
      id="Fact_46d9ff36d5d340629e542aa6d2a4c73a">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20230426to20230426"
      id="Fact_77bf0c51e17c4f15a19efc293bc38d1d">02141</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20230426to20230426"
      id="Fact_e9ac08469a8346ffa484f0ddd7699e98">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20230426to20230426"
      id="Fact_40ab628d3a59422592295f99bc21e3a2">582-1199</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20230426to20230426"
      id="Fact_38c1ba6f7f9e4c019e481cc0516c9094">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20230426to20230426"
      id="Fact_36d72a350f3c439391c320e8b27b39a4">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20230426to20230426"
      id="Fact_a4a65c2577b546988a00c834513e94e5">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20230426to20230426"
      id="Fact_14f045b9ffa44a3cb0b11317f79201d4">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20230426to20230426"
      id="Fact_c81c97ce085640e49662f58445018acb">Common Stock, par value $0.005 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20230426to20230426"
      id="Fact_746a02a0ec4a4311b6d70237a6a40954">ERNA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20230426to20230426"
      id="Fact_83c75c011c2048e7a3658c954cc835e1">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20230426to20230426"
      id="Fact_736770bbfc3f4377a14df6e737f271fc">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ TX.B5APX9>H_ 0  / (   \
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M<F]P<R]A<' N>&UL4$L! A0#%     @ TX.B5NJ/DOKN    *P(  !$
M         ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ TX.B
M5IE<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H96UE
M,2YX;6Q02P$"% ,4    " #3@Z)6P2L]!V($   ^$0  &
M@($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ TX.B
M5I^@&_"Q @  X@P   T              ( !I0P  'AL+W-T>6QE<RYX;6Q0
M2P$"% ,4    " #3@Z)6EXJ[',     3 @  "P              @ &!#P
M7W)E;',O+G)E;'-02P$"% ,4    " #3@Z)6'#AEZC\!   \ @  #P
M        @ %J$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ TX.B5B0>
MFZ*M    ^ $  !H              ( !UA$  'AL+U]R96QS+W=O<FMB;V]K
M+GAM;"YR96QS4$L! A0#%     @ TX.B5F60>9(9 0  SP,  !,
M     ( !NQ(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @
&!10

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="brhc20052311_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://eternatx.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="brhc20052311_8k.htm">brhc20052311_8k.htm</File>
    <File>brhc20052311_ex10-1.htm</File>
    <File>erna-20230426.xsd</File>
    <File>erna-20230426_lab.xml</File>
    <File>erna-20230426_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "brhc20052311_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "brhc20052311_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "erna-20230426_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "erna-20230426_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "erna-20230426.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/currency/2022/currency-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/exch/2022/exch-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd",
      "https://xbrl.sec.gov/sic/2022/sic-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 29,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "erna",
   "nsuri": "http://eternatx.com/20230426",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc20052311_8k.htm",
      "contextRef": "c20230426to20230426",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://eternatx.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc20052311_8k.htm",
      "contextRef": "c20230426to20230426",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://eternatx.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001140361-23-022489-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-23-022489-xbrl.zip
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M7\1%=IUJ/#DT72L*G&%$/>;0P**.;84V,P=!"$&&L8GHU%*SK;A(#^*+.(4
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M_R&[1O'#-$C,XM(+6^WVX\>1FBC0OU#>9F.,"?UWAH4I>H9RD;BIXEE$WB_
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MQ>9I<=N>T:9?-7[CSU4S<L]C]9:_O'?0#S(V/\0?XV*2P(__!U!+ P04
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MEJOEZ05QAOTWH)6]Z]#*45Y=AU[@,E1SC6('EA_PR>S,M9(;G%-O.BHI153
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M<'=7?OTK/(L4#Z].C(X,CGX2?4\F]<3Q G,<!:<E'L%.,EOE4KL[S4)#\JS
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MA]7;LZ9/!"TX?'81CC7]Y>,FJ^MJU6@41L&'DHTA!8>=KCH)+IJ#A>IDG_;
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MF8+VT(C+DVT8/0%!:PJ;K>5R[53%B_/"GYQ-']*=VE*!$-"?R+5Y23)/)^[
M$"_S(EUV38_1K%J4E)]7&2#?V7ZSE&.4W&=C#I6=H<B4_1CJ)"KTPV6Q<93;
MXNKAK)62YDN;K6SI40-MMST+)PA>J#2?FM:KY+<K* 5+L?)LBR>4Y/E'4\KY
M8$5:"[&J4%&E?0HCM,*+I;?ZXU5I(:AF%Z/+3(.2<%TVY8 RT):"&:+S&]>;
M)"JF32.6 ^J/$6/P:1#1TD44U44''&AP0_V$A1)ZI\_L(.8IH!=MRI4SJ")*
M/4?9<41Y&Z\(5@BAZ"5QY[^QQ$YY^YHE7]AWW2=2YPHQY>3,8'@#%5;J^,>0
M./44#T^>*>O)W?FG*3_,Z\J8SN1"'J6S%V PXRDM+<HBQ?LEE5,3&X9A@K8E
ME90 Q%&@$V0!2;-T=ILN5)W1^;O$_-<LLK^[*++?&K>_.MY__<C^XLA](^Y_
MZU"^ERVPS+C^TH3HC:3H<F0IL-&":KP2E);H^,[AE";$MKF")K0(3>Z&2GPT
MJK#/-$G0ZSS*R=G6K1]TS([-7[@VKDV],(B-BR2ORZ!,OK_@[BH2,KN,R- W
M&%KT5C55M"7BEB/#-R\\822X3BOM5K<\>G@ @M";=HV=\HI66C:MNE3IA6K9
MMXW>)B9XP>*!>D$.-LP28!%NE '@.?DH$>>4) ,80;_Q?M.*#%N/K]-&> ZH
MLCBJ!:D*[F68I5N7J.Y%P31'ARAJ<N86KI8%VCE/IN0U(G-H1.$A4>0:V88H
MARAH,AYSP50N>;0D %%QHA)M_I8U0H[.HDO-N$YS3UO16#E:#-(L6A]E@CQ#
M![9_/0C]XC[-AQ&AJI(FJ[Y1.BU]P5:##9,T"#R*T52EJ@Z)]H5^5U9* QAK
M8Y%9W;[P(0\-SX'J;MEKF_F!=BM3MB0L\:\SG=BX%EM[KSNK-]3?"C(,&KO7
M/+QY1KDWWIDO3=3+[$FH<QQ0X3VGZD%=U:=Y&/I%A+&QVQV.Y1CVENMK*;"K
M=YNP!4=H9NJG$I/#YZZZ'^?2MO>:$NJN.SN)OG'\),-^$E2^ 3IA#G]C."HG
M7H[5N6<>IG@04-M.@QB(]GJ=21IQ*9416FSI0QC:X]>P(XT>HP@=<'6[\]!E
M"TLLW%M"RKJ-8W6DA?3%3;G(Z^E%PTBA,?B>)#U# NRQ6'OR/<=\X1"G$6<F
MR/>AS[?%QXGE-EZ@])U$83FI:L;#0F$/'$IG>-+TD\@3-I+:TIH^H5^J4R=.
MT9S&($I!'BL0.6."3T5=YB CU#V#QV&U9<VC.)=>ZU\>^S-=U"CE!E8"/:+J
M.FMM XW^<H2,/&%!!OCMHWRJ."/3;Z+@KLBRBS.<(-5NLTC,R3/&\64*4^70
M28TH! 4HBE(BD:JSA+?1=T+B/$H+(2MX!.Z=3FF"G[DR!$LX2C*]V>X*8+XP
MU_.//3JXT2EP=H9K<(C(<X.KO6"K4&'JVBFO&$="F"4J_#56^U.8#W-$=?X%
M<.#1;#41Q]UF]JJ4TE0:\Y&-&;)G7(>Q*,^W9BF- +LDA^CXR#R*\&HI&%O'
M, =0J19_<V"?AC5A JD8-*4[Z@TS;;,2'C=JKHC]T:(!FY1<^U@=FC]#9#!<
M$WH6)UCC GE:]QS40+,P:JD+Z?97V=2* ).SS>+ R3'"")YU!L5H65KR.DPF
M' *CZ@'TE+"-=XH%XXRJTW%^O45HH[YQ79"VZ(!J,/D1)3:EW<\Z?P.!$<0\
MMAP8OGOA!!07$JZ=)%GQB]BER7(VQ\\RQ;;PBWFM$)(/"6)J!4BGBXW?-Q1_
M!#,G',&9RL^*: IF$XXO8AT=1XIR#A@5F\@@-?]=,YR+4]<1LFL!4URN,P]#
M\@ME03..U!#9AK-SZJ%K@> R>16=GFEA; Z3N'H]!&QJ'+2_:3(/@4'7Z<QR
M]0N#^>%7 2[J2A]R5LYU](-S:M>'8B A='-22G11RK E2A.EE!V% ],3-W='
M$JFK&*_2[=[CQ?2D*QO%N.G@>-MN>QF)M!XJ\U5W>'@HX"]3G8G*[C'#\W1Y
M;9Q;]D$Z),6T&K&KAB/ PY*$ZT& @A&)N&7HMDIS=F'4@I+35 I'KA:8.%I@
M@H(\YJ08%1489$D9==%VDT)75P/R!X_U60Y/DUYO+8)$)Q)QDE8HR6*XUY1Q
MD^5BHR4,B"*:#D6&\DL"KK;&ME[0)A=<U,_2)O>8<",?!XVW@W=AXI<H)!28
MFANW7]>5E* AC!H(. 3*70LN#K,#G2;<93F:7*3Y:BD;M6S/LO#, BD3@^D1
MW >GRC4T2%-D/5_P99Q5H9.:V$PUTSE5S;(GPU@TM.A#:#?=9O=]6]?!+\/"
M#91UCNLYO/@K]E5^#B^N$QCBP^>X'61_U=GH%GV-G<J(R <T-;P^=&P(%XD8
M/L0U V*P L_P=)B\7HZ*9-BJ!G.9*0F$I"@((Y"[<&*S)YM[:EO<3O),S4PS
M*%_2LVH"RB3UW)8B%&N #*F*U6BN#,'1ZJ=9N$*=:!^F<[*I(79Q.U!'P<0E
M1>FU_*7-LIU7"1VUT9%M5FYXF!Z>PK<*.(X.B:*M/-N-U<&<I(!"A%J3)D96
M ?4G@?32?C^P1[A=D:Q;C@$"<B[(>DJC4/3P\/K-$<#<"JL5I6;[:R!:+]?;
M@VJ!6I)&+;(JDH0SE@]+8OI#SL/^-=T;SG(Z2]BQ;KJGD9Y*H^E(V%!DFDB2
M*U_X=G[F92NZ!U?;_ Z+P][ :(8 H6KKTO -$Q >ZTY52Y^+WRG0/TM2,,%^
M1C;T+R.T+9$+:"1*?<1TM1Y:*@T(.P8L"IP">Z>NOA7;P &B069;H1$O_)91
M"&P$]C"Z#'138LP7YD#]:KE/H[VB+D*BP@AW[J9K5^)@&!A,?MS4#1^[P"]E
M7'3GICGJ7FN>I8*P+9@RE_;@3I2$V2V"UBM'"S2\@]3=:< %OX!J@8F#53@&
M;UO7V'L0#K(>*\13:)D[R\D'H33MX FN(AM:$=4&<W'ENG><4Z,'50;[?!U"
MJ+?&/GUX!7J J;Q2<MQ62R\N#:?EEA/5N4^;/M2J(WI]F#Y0<B?LDK$P^551
M<Z>T,97%DY/.\Y)E5 /&?01%XA/MP0SHT2P%+T&:JI#GU(Y\IB91DL5MG@Y_
MD5#[XX;T6G?$M@]27<@UA6$'#&/G6-$_S8\FS9QV"*0^>K>08?Q5%TD9RQ[-
M0:!I-8><CYVOZ-IR&=HD^IY,ZHEN0 (Z;9E82>N+SJ9C6]]KW97J*N^\A6+O
M&-<S;&U;H=Y>HU!/+Q(:SDZ+P:YFC">*U>#;95-0PI*? M5(C\)33$<X"LH<
M]AH&Q/[*TAB+.F114#$RG3-TT[/DX(>>"UZ,*?1R<WR]5HK8*_8B49=R:J)T
MAJ!@7H*/ TC$3E3MM'=0"ZF[,Y<I.+++]9_;1WH>?FR&!'=OVK+[SGB?9AK7
M&/\E>M#=.B;[4DQ&.&-O,(41<(6B&"RSO/"F1*X$.W7QA8<F#(Y+K$LNFDT1
MMH*C7%[665L#/YQXU3VEW;4KND/JT"7Q9;3+,-02&2P6MZVOU]17E#=W5V"-
M1JK(O&V9T2#:L+@2NB$3:62Z3_J].366VY1[V^@6WZ43<)W7WHQ*Y"S=.8%*
MX>PDUBK?$WVF,P%]HD8".EDM7+AL>8%82Z:-0_LZT@:XA6\.LB_/R&XIS=/Y
MS>B#"_?Y&FNRA.0O!%N&+3LX.%ARK9-Y\A_SRKG??=@T%W::I[)>U*0B003A
ML+_C=.R._=_NA+&^00$OJM)S*_J],@W3;TV#T3B[[*/D2"H]O ;!!S6H,!4]
M)B5WWA8=H8V0.BF(PV1A\\"&?B=GW<E,\PW7:G#.<\>*F\AD3F=!M[IU_6K=
M+6]ON0-)*0T2%]8.+SC&K5!!R'XF7%L]+?*_=,H2%S K$(^$Q7*1IQ<-3M>R
ME5L.L$MD+IQ/@[28'DF&?V:8#H#T'V&.(E=/2I&/X-Y0+BZ#R+6/EP*M9L F
MS0BD306WEJP?M[3\DI:3ICT'Z*^U=X[8\3T2@.E&'^+&B.ST.Y=RPU=>;1Z+
M%C/T3@.')<8OL^R6-W:OP:V0[?[62,,OGY&&_Y9FS<MVB$!CW'PA[;S-JNEE
M65Z+?Z]L,6L^4M<HY!NF+;I!!,)F0=;D8=9M^/\564]S!2%9[M2IS3VIQ4Z2
M^P0DL$N<@#E=ZPX24IV&/;(:,*NX.G"170I7->YH]MZEG&B01.W!X#YBMLK/
M;24633'8$)GD9,_$$HQW;?B8:\5)B,\_5VFL>_KXN/"M73565$,O,5 WI.?T
M2%M !!9RVA2JR%Y(LA8!%DL9I4&8O8Y'96"KY'LC2K7R(2[[W\&(SLX4_AH&
M'NA64:?*6$M.M;W2M_C@L$9G<RZ-:-BPOREF0@&1_KO.N30.9/$$MYZM1BSI
MYYZ0SSX:R\Q>=;?7<5C:;Y0&375+\UR-*.*_'*??N^ KQM#(-PG?S^#$@N+\
MA-&6EN-./VT K7(B OF41R8-NA%ZU=#61@6U";$F3R1W0B.-1EVZ.PNQSC%?
M:=OO-GBQ]2#KI/CAS&21L^.[M?$>,,5\@BKH*$BC2S.&027BY@.\\C*20D@<
MB;38%E1,W<Z3FV(VFL?DV3A-N'85'N(V!"J(MP0;!K:^ZZV>7>+ZKC>9&PK8
M7:336(47NCJ_GA8^Q_-^\T/A,5G[R]<AO/0T*O1\_C3@VG3<BB_8W+(LKY6_
M^8B*6F^!NO#(=Z7+S2\>'. UR!"M[T3'X(!A:RT0<]LN\A%USB[KX22QJ-E8
M/F+[0OF'E ^Q80C[%,R";_?/"?5JIK70WS/":Z!37 8?$@E4T_5ED.8</0 >
M^#5)@2>?57GFI4:WLQR.G4E.F_^*MH :92.P"PS'.%32> 3O+I.J1K@&50BK
MDI;IDD,0%;F#"^&"03B)!CK%'<<XR;4BK4,(UO\$7T\VC0#1,4N)7U(HD[2\
M!I!7JWO,%WO <(Q6'YEJ"BD<PC HMV171<7-+2,:SB1GWQHMCVF2ZN5:2)X/
M>40TX+7;*-K4W.%+M+=R2HXJRC432FJCG6@((O%%%B$T-NUG::(77LX@R"=X
M(#O6@9(1E(8<XI,:3#/N&5Q50/3:]C'4+H]KC#\84DDO48^8A^VC =E-4FQ(
M!@J&/3DMGZU\DEU %?4$CPENT(7*$H5A('N?[A]:L&H-&D5^P0F(-@#LB#L[
M'*\^HF6=B!K)R==F^>E]F*!_KY!#+]US*TZ%-$5YY&C6O8[QZ>O!R9\&*U\L
M4N<8NC[BR+W=#@>E?<R4'Z//;8,_M:FQG5SH6JRGT56'\@.JRF+5'+*6YV?"
MMBAUS,+<0MN627'(>%Y=!F:$BB8N2[,W$#5C0E[(.1/=*^5R",H;'&U>Q4IA
MR M9:1-*R;#5S?:7>ESU=M,W+=EOL@3KH%#?J,CAT9[WJTQ\7:/VJ1]\P3XU
M_4'PJ7_2?_]G\+5W\$<_#'I''X+]XS_Z1[VC4[BLA__JPZ\'AX?!T?%IT!L,
M^B>GP<;73WWXX00^!U\.>P='IP<?/X;!A_['_M$'O/7X)#C&"[X>#/J;^-@_
M@Y.#WS[!XXZ#TY.#WF$ [_ROWT_^# Z.Z-?>_NG!,?QY<C X./H-O_WZZ?BP
MCP^"OW&PP>]''^"-](5+]?O'1T=]OOOKP>DG&/#!(.C]=M+O?^[S2/#YQQ]I
MUG#Q:?\S#/FT_P$&TCL:\(L'8:"G='3\->C_WX/!*8X#[L8%ZGT\Q<GRX'B5
M].6#8QB7#!F??@(/#&&:)_XBM"T]#9)7V0[Q<_"Y]V?P\0#FWH,'?I'O84YP
M&]S1^_*)YPFW^,OP^PGN3_#UY.#TM'\4]/\X^- _VN_KJ?\W3(Q&_\?QX>]'
MISU8>YS'^][);["!_0\O/N)2F77K?3Z&2;G#/3@YZ?]QO-][?_@G;B-1#%YP
M<!*<] =?< _@"]KFP57[_!4F/3CN_P$+^+Y_^K4/X\6WZW=^AB?"'N&RXH,Z
M=M2=_I6;>[#_R;P<J?G@:'#:[\'\^SA0N $'**L(*[9__/E+_Q1?!Z,_&'PX
MX%MA-CWXYL-O_6  RXP#Q,TX_OV4OC_Y\[E#Z.WB=J^>XW9_2U?WZ\YTQ'Y6
M45E#:\RNI8F/+<!NK3'O92-0W;"@P_Q6NEH,5RWC*QT4DGEC>\H)#DXGGW9C
M2% 6$#LN)IM?XE[BFL7 60[&FT*X2_,^,+QLA3F\ CX[.2J.T4H)10Q"J3,#
M=1_01HJ7[ULV68:V&XN?:5*:=MJ)#]2OK79GL*U:?T>J3?LBV3PPF_WE59(Q
M+M!S=,@[,C]=U6KC(U=[M1Z<LJP+U.Q;(]VFY8T7Y+:P ':;=6,ZW4_;NN*[
MVK-2QTG)B',3XJ1W7,R%/$"])L$KI"*D0G\@#\B,QAY(?SV9"A.U22XRQ6XZ
MH\8Y.!(Y-AD[,Z]MYPA(?Q:8HDQ;L.@<:LS4=Z(@5./HQKY';E2<C-16=L2'
MJ8TI/5.[1^UOKJ+VQ>4JS4,@U2M.3&H.[X+J1U(-YN*70(S%U\H$A.% &X&+
M8EQZV/4BLBXW;):(\>]D; HB0@]+!0Y7HBZ4%'=43KM(?=;F@WY"=Y@.A^UC
M&P47;M-+W4>*>BC-);+/5^2V!!9C_$(;]P[BEHM#VS629U)V2?GM5:3<@Y6/
M<?7GR!;_8>.^A6\?84\UN9-31;47X"I2UXAJ=G.'"3==J+.4G%>"=T<*A0;[
MX3Y9IN2?JB]RZ3,MPP@-ZLM"1 $-$>\]1L8?BHO/R<?4*:O&Q2CH.83-C<^0
MF2>E'%[3LM%9*KG&RQF:PRMPX!^*L-%'C89LDDA-H;*K1H4V79>*$*0^R?3[
MM H;'WF6?'G!'8KTKLC)<VM;Z8 9![^IA@7UJ@0Y9FO;0SL#.WPI:_<&'UH_
MX<VF0+$H%H.R!.BI=*"_M/\7%OHB*:I:68*<'S7G@7.O.Q#ISG:!FH >4,?1
MF5.%&!42&3YIGJWSO1LEP#2F4 "C=.[%K+THE;$RIPCP)>UJA&2DPO"9J[E<
M;6?[2@%=C] +G!=E5U$9]VXN:;_!?"OB%]1@-WA/:*>C!$BI56'M65#3A3@3
M3CO:F61RTTT.FNJ<<DMME#4SG(K3/LDH'R]ON=O7>TLSY]")67"+03?%'.^3
M84M,L]'SJ'1QQ9Q&PR[:A(_?WR+%-0(,O9[DMLO]WID'2$#3)B7R'19W8?[=
M[3 *.FD(;=3SJ. VE92>WP;;8GC*)C&V8 !\(8FI\RQLE,V"W?!;*7B]J3T
M"2[$I2(61V<CHP$-\4@P ^>FL;Q*Y9VM[9<N)"AQ2TL5'D_'=3'0CQN)SJTD
M>4A\T=Y&O4&EVW/$Q-] D[0MH)UE-9&^EKHKLXIL:X<&S$(P>1MPMYC<!2LE
M)\*VXFHD51D)S4*_ZW#X::GS!X5>P:!&&'@'2ZVB+=7HDG/X AQL9NV\I6;G
MF7,OD?'OM#)^C_U[4J"X2"[:PU%S6#J.DXE3W&V9VO+.Z*L&FH"?']WPB]&P
MK&ML40FG,*&2)LR^#F%(3E?Q9BW!<Z'/#0,&KY\#!L],Z^9,:[>-9P5=3.N
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M%]NOWKQ]Z%WI9.1WW82(%C_^S[,JC2YOR;B?V^K^NO/3<UO=!S>DU*,QI+A
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M5(@60.O$;2OQW6[!;H^ "Y(;2L,U(B"-8M9)0VU]W:UK4.-L81,64K3X"[N
M[>U_9=O3E'=1/K"^9GJ^\L7NC53;PUVG\ 8G^;HYHD ;JHRN@$UVG.$A,B?:
M,NY%I,G":HP0SH&P$>!A&K=L1A0F#7] 6+-W@,:$AX(KSLUX'7^5'OA00P8"
MER*,43J"<%C FJI@O_ZIC732$W3)\RB:)D".L,/YZ!N]IG6R(77M<>>G6_/R
M:+GYIEX\%.P$PR'*(J:[\[S+:TS<^)?U[$O"2?>&9>>OQT>5.[$_1F,DM&\@
MH>.Y*'OPFAC%!ALLW/RG),*KSJFU&:["IBE'1XG0W7W:[@?^=IDMWHL^,;*
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M\HCR9W)TH/TJ]6EQC<Y*;"NOJ)4EB&+1!,A;P%?J#(;&EU1!TGR 6\OB=0C
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M,>4 )DJF))()>1^JRQ\XWD8#3S?523N#0&S$F.=JFILGT#\]?;!F*8#]62F
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MM]WMO98#_W8*F<-94U%2N]>?=*;N%=<[N1!D_I,R:*^W#!3<_K6B?*TD"''
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M3C6R^+(^^KW?J30'_Q3.C=YW>_;]4QP4\YJGF8N-$/,X*LFN_P)02P,$%
M  @ TX.B5C4GP9]_"   =%@  !4   !E<FYA+3(P,C,P-#(V7VQA8BYX;6S-
MG%UOVS84AN\'[#]PWLT&U'8M;\,2-"ZRM"F"I4F0I-@7AD*6:4>8+ :4W#C_
M?J0DVB)Y2"D5)>NF=7C>\_+K.9*L1'KS=KN.T!=,DY#$)X/)Z/4 X3@@BS!>
MG0PVR=!/@C <O)U]^\V;[X;##SC&U$_Q LV?T6^4^ L:+E88W=Q>+\,((V\Z
MFHZ\T<^3GWXMA8=#GAZ%\7_'_)^YGV#$NHV3XVT2G@P>TO3Q>#Q^>GH:/4U'
MA*[&WNO7D_&?'R_O@@>\]H=AG*1^'. !8OKC)&N\)(&?9F,NI6_G-!(&T_&N
M+Z."_S04LB%O&DZ\X70RVB:+03%$'J[1B9!O-7TQI\G1T=$XB^ZDS"BT6.^F
MS58/H7S]*(GP+5XB_O^GVPMC]M&8*\8Q3B_].8Y8EUEZ^OR(3P9)N'Z,L&A[
MH'@)^T24[FSXZASQU9G\PE?G^[WSN,GP5ARF>Y+ZD9MQ9G[Z6+5NF@_ZRM72
MVH9\Y7*569'C#E:YU$WS0=]@&I+%^WC1_L#5KEP-_B[U:0>HZ)TUGT#[HP:&
M&O&F2_9)ZA=O4QPO\$+TS+TMQ\ZLZ^Q@FSGOO$D@N4;\+$*H/IV$N6:."0Y&
M*_)EO, A<_8\_F'(/V2S8#]\/B/L]'DZ3U+J!ZEPRB9Q,@!C:9CRL2NQL3Q0
MGB\-E>*$;&B E1ZT$7R.YM&+%DG:XWQH)M-UQ+KE%P8X'GZZ&Z!P8=+.LB;T
MCVC\]\UX/VI]IJ=4WA>?!F)([&/%- K%."#L9/F8#J49+2E9F_:!5"Q?L1J9
MWS&29"@ER) [;IVX=R38K'&<WC-'!0<H5$Q##C7 K6SDBC; TP2;)IV)%L2;
M#@L:N/[$OFXR9F65H$S/;!^R/VB8LD/N&5FO-W&87VPG"@U633$M@Z8!?Z"C
M*Q!MYB8BS3FS(H3DV&$9M>\:J;G(,K6@7.!K\6J?XSL2A4&8LN^S']D%!PW]
M2$'*+"BF" D:X*O;N6+7Z&P"UY PV[<C$3@LLI8](G565895UPI232[M8WI#
M,:\/S)8@.]+SBUUZO5QBJB!4+2PF:Q,VP-=LZPKCRAY,.%<DSEA\&)0$*%>@
M3')8P&OL*GG)^LO FW,$^%6NG1? 19)L,*U=!D8Y7 R W%U):.8M%8:IGYKE
M :?K19+K^ELKYJV'*\:Z/=:ZT3(-U6/HH?T:.F6]+_@(SB-_I8 *QHKI*K$&
MI2 YN>(>,C5!KFMGNR;$VP[++KP+I&+Q9"HEF4 0R.WN1L1YF 1^]!?VZ3EK
M4;\E5JB4VQ.:RL&="L73]4T+V+[J_@64M;^5D4<1#Z,LWH_[&J8])+47'+[;
MH22H-SY OZ[YSN^P5Q,.Z$#&)9TSRDNN[7"N=U"/=#5/8ST7](]V:#]!W@U+
M;R.^E (SKWEV1_WN%V+OV'=A _&@1J%=T3@@77)T33ED7D6XGK.GN\":!1&/
M]H-L>-](S66&B9;D*LV 5_LDOX_92)]O\2KDOZ")TRM_K6)EDQ33A"4-,(8,
M75%L\39!;$R9Y1&T#R$>.RS!U@TC]198YA=2"WS-3EW1>\:*A_K1!?LRN?T=
M/X/X&C02OYJF,<"*HUN"87,[PE".8+B(H2R(6+0/%)OVC=1<9HAC12Z##'IU
M1?)Y&.&KS7JNW<LSA25^R^'&Z.[-W%*K^=J!5>2"5=Z,\O8^4 IL#*E>3(C-
MO5+&4G7HBLA[?WNQ8"41+HO?2EKPK-!*K!JUC<$U.+NEV-Z)'6E;KN";:9 L
MZA'M5?M,7K@=4!T8TN2BL'IW52$7<4#H(Z'9 .Y2=NU^1C;L'/)\1A;PI72M
M#*E:*C(:UXS5WVWEU.G*7C_5#J**).4KE&D1H:C0(Y[0AX*J!P3YJAV#BLN:
M+)=8C7ZZ*K3W:TQ78;SZ0,E3^G!&UH]^#%_L6Y5281F4C0L*]'5;2+8N[ 5D
MSA2%(Q0HEZ!"TX=:L>\M>=$F0+4!)LDU8?'MJA9.%PO&8%+\=QG&> )6@D4G
MU0&H:UP%@*O;&C!W8*\ 4Y[@OPB\$A\0EZ#KN!=G"]N>DA<L/T0_D"*S;_0\
M'/E>3?*]FN1[K9#OM4V^]Y7D>S7(OW\B_23?JTN^]W+RO2KRO4.3/ZU)_K0F
M^=-6R)^V3?[T*\F?UB&?;5A/C_K3NNQ/7\[^M(K]Z4'8/V,?K^D]>8IMY.LJ
MB/NRRA7U>\]6F-?L:Q&O9&F\\SC_5LP5/2(=V$6(<WC)+93O$T#&5;^."<^^
M8E_3&TJ^A+$&7!TIQ+HF=06\8MP*]7 ?M="'4C7^=[>%A*Q'16#:8Z@2+'MA
M*0<E"ZP)T+GK0W]^V\EZW)<EX$%?2)P=\7/#=@[WDG>]8WTI13_0Y\$>X:WN
M&'B UU?8=G0O;NV"A_:R4\?XWI D]:._PT?C;P5L0@AE1>@*:,FV%:RA'FK!
MK2=JB.<2Q#2]N;EOW5<(>.,.6+"7<D#X =?V2X!?3)U2[ /00Z%B@G*HR5L?
M2D;.7OJ@>QK?^:!*9]FE-F_J 9W@!A#[PLD$EE6[MSUHF>U3QE]T%=T\D!C^
MVQE3N)B,'FY G&KFBCJ#KXD\4#[+6E'6W(N_)C!N#*E>3)E$52EHA!TZ>*(>
M!QO**F'BS>_Y0!523.%B4GJXR;/TBIFS)^EA7^-S])!\EGU$9(DFW@_S'Y$0
M'?A)>M/ND.H5E;%4E;MGZ$&']K&\(O?4Y^\MO'M>STD$/ )I4113 Q4-^ 3\
M7"%JMC91:LJ871%41% >ZL&#DK:](K465Z85$ M@C3[M,RMUK/ #QHI)*;$&
MA$I.KMB$3$U4ZMJ9#.-A.81W@50LGLR>)!/4 ;G=G;K?;X,'MAD8>"#&)E%.
MX;+$P6F\;.CZ5 YX5YW.M929B" 1ZL$#,=8-(_46&#ZSE]7JV5UW*M[A6%J+
M2_:)O_FW: KS-^7._@=02P,$%     @ TX.B5H*LOZO:!0  \3X  !4   !E
M<FYA+3(P,C,P-#(V7W!R92YX;6S56UMOXC@4?E]I_T.6?8:4T)F=5F5&;&<Z
MJH9IJ\)J+R\KDQBP-K&1$UKX]VL'NR6.[81>1J<O7'(^'W_'WY?;(9Q]VF1I
M<(=Y3A@==OJ]HTZ :<P20A?#SCKOHCPFI//IX\\_G?W2[7[%%'-4X"28;8/?
M.4,))\D"!S>WUW.2XB :] :]J/>N?_QA+]SMRN$IH?^=RI<9RG$@IJ7YZ28G
MP\ZR*%:G87A_?]^['_087X31T5$__.O[>!(O<8:ZA.8%HC'N! )_FI<;QRQ&
M1<EY;_AFQE.=8! ^S.5$R&]=#>O*3=U^U!WT>YL\Z2B*,MQB$@W?U/"JIO[)
MR4E81A^@(A'QI'XH6ZQ>$.S6C[,4W^)Y(-__N+UTCCX))2*DN!BC&4[%E.7P
M8KO"PTY.LE6*];8EQW-[GI3SAS1R=4[DZO3?R]7Y]3%S^!QZ"VFF*2M0^C(\
MRWQUKK5IGD_ZZJ66UD?YZB576>SD^ >L\MXTSR=]@SEAR1>:O#YQ<ZJ7(C\I
M$/\!5JE/]OP"7I_U 51Q@3E%Q:87LVR7^C.+UQFFQ8@*V0I2;"_IG/&L/"\T
MLY;9!*MH<'0<[3CY\^US7'&<"V 9&8L-E<GPIL TP8F>3G)]:A7EG'K6E,65
MB5)Y#F2\+D8N)BJ5R''<6["[,,%$J!M%\H.L.2KK%5_^/6?BY#^:Y05'<:$S
MI5*58<<:$PQE.48L?'6B>IFF(J/!TQ92-*NA*LM]$4>\RACQ6&<2'RL*UD_4
M"A&N$!?YNO&2I _BSSG+7"O)O-3WZ9T&E0Q!P8+J2,83S(>=(WG])@;.,>=J
MY_+P+DFG^WO@:PHX$FP3R?@B10M#06M,K8,1@Z>ACWR#B,90I6(?L(K:=@]G
MR\_B,.[8'ZT88\<T,/#4;5-,RUW52*'4CMZ VA<DCU'Z-T;\0FS)'7H[4(;B
M-11<S?T%M52]ED3I/G@SNN]\VZR\!6?5OH*#KKZ[J(/TKZ11#C@&[(#=I>@%
M2?'5.IMA;@CO"JNEJ8?AR=Q00H.Z]=%*U'?@1;W%"R(+H<45RLQSMP]2$=>$
M0!786THKD<T,2NCWX(4^%Z5QE%Z*F]'--[RU*NW 5*2N8:!J[2^FE=BU%$KM
MW\"K?4ECQE>,E_5-1)GXG*U%,=MSEMCW\E8C*DYH& '5%X<4VLHE#0F59SZ
M]\P4;2X342V9D]W/*9Z3?0.VXA,G%JI#VA77RAO.5,H5)^!=,4H246BNWL:$
MXK[5$1Y<Q0U6'%0G-!?5R@76-+J_ [E-YZ(?M;1 U-("T5NR@%G4$RT0/5H
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M>&<TE7B8/RS9M$N>VTL["VM+.!8;Y-_.=Q'Y(O^F_?%_4$L! A0#%     @
MTX.B5D&GSW)Q&0  >YD  !,              ( !     &)R:&,R,# U,C,Q
M,5\X:RYH=&U02P$"% ,4    " #3@Z)6.0RN-2F#   8U0, %P
M    @ &B&0  8G)H8S(P,#4R,S$Q7V5X,3 M,2YH=&U02P$"% ,4    " #3
M@Z)6#M^B@T<#   Y#P  $0              @ $ G0  97)N82TR,#(S,#0R
M-BYX<V102P$"% ,4    " #3@Z)6-2?!GW\(  !T6   %0
M@ %VH   97)N82TR,#(S,#0R-E]L86(N>&UL4$L! A0#%     @ TX.B5H*L
MOZO:!0  \3X  !4              ( !**D  &5R;F$M,C R,S T,C9?<')E
:+GAM;%!+!08     !0 % $L!   UKP     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
